{"meta":{"query_hash":"df1fdcca5102","filters":{"venue":"Vascular Health and Risk Management"},"cohort_total":59,"direct_labels_cover":1,"predictions_cover":59,"exported":59,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/df1fdcca5102","api":"https://metacan.xera.ac/api/v1/cohort?venue=Vascular+Health+and+Risk+Management"},"results":[{"id":"W1707073606","doi":"10.2147/vhrm.s63060","title":"Profile of betrixaban and its potential in the prevention and treatment of venous thromboembolism","year":2015,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Apixaban; Rivaroxaban; Edoxaban; Dabigatran; Warfarin; Intensive care medicine; Vitamin K antagonist; Deep vein; Heparin; Ximelagatran; Pulmonary embolism; Direct thrombin inhibitor; Thrombosis; Atrial fibrillation; Surgery; Internal medicine","score_opus":0.041651420892191426,"score_gpt":0.34601265207517806,"score_spread":0.30436123118298664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1707073606","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006665403,0.9867082,0.000014811055,0.000056395707,0.00009294821,0.0060860906,0.00003853665,0.000010817663,0.00032677304],"genre_scores_gemma":[0.000971361,0.9981261,0.00027680307,0.000034720524,0.000068300586,0.00030894348,0.00011454598,0.00002975132,0.00006947504],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976278,0.00038943888,0.00078553084,0.00046671086,0.00041125162,0.00031924996],"domain_scores_gemma":[0.9987346,0.000034714067,0.00057041046,0.00042353285,0.00004425463,0.00019251413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010722826,0.00034401016,0.0024958255,0.00038945687,0.00009502317,0.000017458666,0.00009398276,0.00012707907,0.000007180875],"category_scores_gemma":[0.000012154334,0.00021112137,0.00023644257,0.00027933472,0.00006977359,0.000039577077,0.00011817156,0.00013723552,0.0000018717469],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013622237,0.0013230043,0.000074045674,0.039902315,0.0010476655,0.000019826644,0.0009887993,9.395602e-7,1.6529441e-8,0.0008570177,0.00023129767,0.95554143],"study_design_scores_gemma":[0.0025526846,0.0039739134,0.0056888666,0.0074810516,0.0064721475,0.000025450714,0.000865167,0.000036561694,3.3566346e-7,0.00018744022,0.9724878,0.00022859046],"about_ca_topic_score_codex":0.0006692344,"about_ca_topic_score_gemma":0.000055593948,"teacher_disagreement_score":0.9722565,"about_ca_system_score_codex":0.0001041342,"about_ca_system_score_gemma":0.00016161795,"threshold_uncertainty_score":0.86092794},"labels":[],"label_agreement":null},{"id":"W1810783489","doi":"10.2147/vhrm.s3512","title":"Guar gum and similar soluble fibers in the regulation of cholesterol metabolism: Current understandings and future research priorities","year":2008,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Cholesterol and Lipid Metabolism","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Cholesterol; Dietary fiber; Guar gum; Bile acid; Sterol; Metabolism; Medicine; Lipid metabolism; Biochemistry; Biology; Food science","score_opus":0.07922894444813684,"score_gpt":0.37800541070263327,"score_spread":0.29877646625449644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1810783489","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008054546,0.9951472,0.000017625278,0.00058942335,0.0003193433,0.0029434236,0.000015399432,0.000013710048,0.00014837224],"genre_scores_gemma":[0.000029030536,0.9986822,0.00025438113,0.00015668418,0.0006012332,0.000097643366,0.00004963597,0.00003275534,0.00009641762],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966598,0.0008046976,0.0007218562,0.00056525675,0.00076114724,0.00048723942],"domain_scores_gemma":[0.9988227,0.00009991797,0.00030605614,0.00047240924,0.000056722773,0.00024218105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002387161,0.00035225318,0.0014758823,0.00066908135,0.0003375537,0.00005735983,0.00013240604,0.00017427924,0.0000035201294],"category_scores_gemma":[0.000021394415,0.00022047297,0.000189462,0.00050100003,0.0002757901,0.000090775764,0.00017073809,0.00081552455,0.0000010368899],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024469122,0.00006832358,0.0001483525,0.039019085,0.00019924036,0.0000040777745,0.0025880008,2.2416684e-7,1.3142079e-8,0.0013553633,0.0017701462,0.9548227],"study_design_scores_gemma":[0.0015626546,0.00010869303,0.0066439747,0.0050269556,0.00067632,0.00004419021,0.0019929558,0.000009655864,3.355639e-8,0.0002475574,0.9835291,0.00015792543],"about_ca_topic_score_codex":0.00021092608,"about_ca_topic_score_gemma":0.00004977083,"teacher_disagreement_score":0.98175895,"about_ca_system_score_codex":0.00008640291,"about_ca_system_score_gemma":0.0001657556,"threshold_uncertainty_score":0.89906263},"labels":[],"label_agreement":null},{"id":"W1824620580","doi":"10.2147/vhrm.s3467","title":"Update on the use of Trandolapril in the management of cardiovascular disorders","year":2008,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Trandolapril; Medicine; Cardiology; Internal medicine; Heart failure; Coronary artery disease; Angiotensin-converting enzyme; Diabetes mellitus; ACE inhibitor; Myocardial infarction; Nephropathy; Blood pressure; Endocrinology","score_opus":0.08125878746746061,"score_gpt":0.30186641646274665,"score_spread":0.22060762899528602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1824620580","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003087908,0.9950012,0.00007227046,0.00033570782,0.000076288656,0.0039116666,0.000018550789,0.000010501307,0.00054292224],"genre_scores_gemma":[0.00002648498,0.99828666,0.0003798482,0.000950093,0.000029284054,0.00021986735,0.000026445954,0.00002834321,0.000052970616],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970453,0.000713757,0.00078105816,0.0004120709,0.0007375925,0.0003102515],"domain_scores_gemma":[0.9982008,0.00016525704,0.00031582545,0.001208794,0.00003070415,0.000078622455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012002022,0.00034694342,0.002314701,0.00023658504,0.0001841469,0.000009959296,0.00021510638,0.00008915421,0.000004458292],"category_scores_gemma":[0.00000964529,0.00015874708,0.0012082468,0.0004425853,0.00013262186,0.000022203989,0.00013312281,0.00037557274,0.0000048138845],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000324665,0.00020635413,0.000020544985,0.035773695,0.015136166,0.000044913984,0.00028841247,0.000020184256,1.2315912e-10,0.00084149785,0.005921505,0.9417143],"study_design_scores_gemma":[0.0012079116,0.00013639565,0.00017258023,0.0077311257,0.011524815,0.000011119841,0.000375185,0.000005394762,1.4165777e-8,0.000022790407,0.97868454,0.00012810109],"about_ca_topic_score_codex":0.00039497757,"about_ca_topic_score_gemma":0.000017544324,"teacher_disagreement_score":0.97276306,"about_ca_system_score_codex":0.000014918224,"about_ca_system_score_gemma":0.00004134195,"threshold_uncertainty_score":0.6473518},"labels":[],"label_agreement":null},{"id":"W1827812019","doi":"10.2147/vhrm.s2132","title":"Management of venous thromboembolism in patients with cancer: role of dalteparin","year":2008,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University","funders":"","keywords":"Medicine; Vitamin K antagonist; Venous thromboembolism; Cancer; Anticoagulant; Intensive care medicine; Low molecular weight heparin; Heparin; Anticoagulant therapy; Internal medicine; Thrombosis; Warfarin; Atrial fibrillation","score_opus":0.011583499158459248,"score_gpt":0.28666112429001134,"score_spread":0.2750776251315521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1827812019","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032242811,0.98850054,0.000015638983,0.000011476475,0.00012749677,0.0061866804,0.00006859607,0.000029012717,0.0018362713],"genre_scores_gemma":[0.0002442567,0.99746275,0.0013255406,0.000057821246,0.00003549447,0.0005131727,0.00021271346,0.00008968844,0.000058561433],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99617857,0.0001911154,0.0013503953,0.00079839444,0.0008284259,0.0006531215],"domain_scores_gemma":[0.99749875,0.000025269976,0.0011081529,0.00097344746,0.00007497747,0.00031937668],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039391321,0.0005931307,0.0043211007,0.00071199413,0.00012737792,0.000009550053,0.0002601949,0.0001553182,0.000026329844],"category_scores_gemma":[0.0000034645057,0.00044158762,0.0004102471,0.0006986499,0.00012498633,0.000051515097,0.00033559094,0.00033537357,0.0000060116936],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043793352,0.002335214,0.0047255955,0.098055884,0.0040830793,0.00003654011,0.000265922,0.000019881743,6.2623046e-10,0.001121365,0.0003250279,0.8889877],"study_design_scores_gemma":[0.0030406788,0.0010847377,0.067651525,0.033643328,0.0040334207,0.0000025816958,0.00024290515,0.000005491446,1.1347737e-7,0.000041601925,0.8898773,0.00037627836],"about_ca_topic_score_codex":0.0024896145,"about_ca_topic_score_gemma":0.00008310699,"teacher_disagreement_score":0.8895523,"about_ca_system_score_codex":0.0002819109,"about_ca_system_score_gemma":0.0002039226,"threshold_uncertainty_score":0.9998036},"labels":[],"label_agreement":null},{"id":"W1886441546","doi":"10.2147/vhrm.s8222","title":"Effectiveness of percutaneous laser revascularization therapy for refractory angina","year":2010,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Pain Management and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences; Public Health Ontario; McMaster University; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Angina; Canadian Cardiovascular Society; Internal medicine; Revascularization; Coronary artery disease; Cardiology; Quality of life (healthcare); Percutaneous; Meta-analysis; Adverse effect; Percutaneous coronary intervention; Physical therapy; Myocardial infarction","score_opus":0.018540320182232697,"score_gpt":0.32080318466268715,"score_spread":0.3022628644804545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1886441546","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012730646,0.98740405,0.001997667,0.000012288863,0.00019905048,0.009900075,0.00003356316,0.00005294688,0.00027305476],"genre_scores_gemma":[0.000017615639,0.99541247,0.002621827,0.000058162183,0.00008201046,0.00061426504,0.00081966433,0.000076057135,0.00029795835],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976465,0.00052145944,0.00054325565,0.00059904176,0.00032744592,0.000362261],"domain_scores_gemma":[0.9983411,0.00020271355,0.00044345084,0.00072131556,0.00006807408,0.00022336378],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018675535,0.00042969745,0.0017416576,0.00039203026,0.00017628551,0.000018595218,0.00010803654,0.00023137456,0.000008740738],"category_scores_gemma":[0.00003947293,0.00030199875,0.0007870761,0.00024518682,0.000051933876,0.000033690063,0.000060023143,0.00027346524,0.000007649242],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096019736,0.00036773796,0.00006942395,0.13174537,0.002330597,0.000025328998,0.000031716776,9.757566e-7,5.190438e-8,0.0003274852,0.00009906253,0.86490625],"study_design_scores_gemma":[0.0022941774,0.0008802902,0.0002092792,0.00953583,0.0034571115,0.000018455328,0.000019937454,0.000017763794,4.3096972e-7,0.00009149325,0.9832486,0.00022666549],"about_ca_topic_score_codex":0.000060502167,"about_ca_topic_score_gemma":0.000003473737,"teacher_disagreement_score":0.9831495,"about_ca_system_score_codex":0.0001537077,"about_ca_system_score_gemma":0.00014282635,"threshold_uncertainty_score":0.9999432},"labels":[],"label_agreement":null},{"id":"W1939039978","doi":"10.2147/vhrm.s3748","title":"Maintenance of improved lipid levels following attendance at a cardiovascular risk reduction clinic: a 10-year experience","year":2008,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Alberta Hospital Edmonton; University of Alberta Hospital","funders":"University of Alberta","keywords":"Medicine; Lipid profile; Cholesterol; Internal medicine; Medical record; Retrospective cohort study; Lipoprotein","score_opus":0.0219923866325342,"score_gpt":0.2726773774479245,"score_spread":0.25068499081539025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1939039978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9164774,0.07155483,0.007502928,0.00011100532,0.00056184095,0.002813995,0.000035358375,0.00011667512,0.0008259765],"genre_scores_gemma":[0.6389879,0.34285325,0.01513192,0.00025072249,0.0004547371,0.00029835626,0.00002497148,0.0000779585,0.0019201975],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959239,0.00040725473,0.0008928582,0.00096446194,0.0010331081,0.0007784668],"domain_scores_gemma":[0.99716586,0.000022831528,0.00043131897,0.0016318583,0.00013092665,0.00061721564],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026330913,0.00035199008,0.0012624945,0.00019456555,0.00073823857,0.000012416375,0.00015777523,0.00013627089,0.000069838614],"category_scores_gemma":[0.0001234614,0.00029287607,0.0015749326,0.00046748464,0.00018658342,0.00012776331,0.00020543872,0.00034691687,0.0000323032],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016378693,0.0009856059,0.06406499,0.0068527246,0.016628861,0.0003773125,0.011565372,0.0002519686,0.00009043946,0.00014878319,0.0056402497,0.8917558],"study_design_scores_gemma":[0.022319088,0.0028098535,0.16362263,0.0015474034,0.0029877585,0.0005824616,0.0077696014,0.0008013008,0.00049200223,0.00008870003,0.79574484,0.0012343366],"about_ca_topic_score_codex":0.0024031631,"about_ca_topic_score_gemma":0.00002961619,"teacher_disagreement_score":0.89052147,"about_ca_system_score_codex":0.00029636413,"about_ca_system_score_gemma":0.00020384224,"threshold_uncertainty_score":0.9999523},"labels":[],"label_agreement":null},{"id":"W1960615162","doi":"10.2147/vhrm.s3810","title":"Effects of study design and trends for EVAR versus OSR","year":2008,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Aortic aneurysm repair treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Medicine; Perioperative; Randomized controlled trial; Observational study; CINAHL; MEDLINE; Meta-analysis; Randomization; Surgery; Internal medicine; Psychological intervention","score_opus":0.04369874915387859,"score_gpt":0.3593300322659474,"score_spread":0.3156312831120688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1960615162","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012393446,0.98867196,0.0018174124,0.0000063931884,0.00014221482,0.0091353925,0.000007126637,0.00003909161,0.000056455898],"genre_scores_gemma":[0.000013011329,0.99131894,0.007277623,0.000025138315,0.00004652649,0.00087371754,0.000046390956,0.000053010557,0.0003456659],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977519,0.00040385936,0.00061282626,0.0005672314,0.00032058914,0.00034362622],"domain_scores_gemma":[0.9984505,0.00032288738,0.0004122002,0.00045214462,0.000025497771,0.0003367343],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004656338,0.00038824798,0.0018476805,0.0003357338,0.00016867505,0.000006629619,0.00006761142,0.00010565219,0.0000024494104],"category_scores_gemma":[0.000051805295,0.00026931582,0.00035760505,0.00022051197,0.000051863462,0.000018916067,0.0000835715,0.00014410027,0.0000030081296],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017092041,0.00058161246,0.00008312897,0.061674196,0.003577672,0.000114461545,0.00017786273,5.818606e-7,5.508305e-10,0.000013575729,0.0007423071,0.93286365],"study_design_scores_gemma":[0.011265534,0.0077116354,0.00056255056,0.004128825,0.014258002,0.00003439601,0.000101317084,0.00004418408,6.421585e-8,0.0000060758166,0.9616602,0.00022721008],"about_ca_topic_score_codex":0.000090817986,"about_ca_topic_score_gemma":0.0000021478068,"teacher_disagreement_score":0.9609179,"about_ca_system_score_codex":0.00012515835,"about_ca_system_score_gemma":0.00011787012,"threshold_uncertainty_score":0.9999759},"labels":[],"label_agreement":null},{"id":"W1984365947","doi":"10.2147/vhrm.2008.04.01.1","title":"Gadofosveset-enhanced magnetic resonance angiography","year":2008,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Advanced MRI Techniques and Applications","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Magnetic resonance angiography; Radiology; Magnetic resonance imaging; Vascular disease; Angiography; Stenosis; Nuclear medicine; Surgery","score_opus":0.021559094900437194,"score_gpt":0.33884892968621055,"score_spread":0.3172898347857734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984365947","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[4.1464452e-7,0.9740287,0.01939378,0.000042623396,0.000042037398,0.0037521238,0.00003886641,0.00018772559,0.0025137162],"genre_scores_gemma":[1.6851841e-7,0.9345827,0.06314608,0.00030763994,0.000091945505,0.0009889791,0.00018570691,0.000060169477,0.0006366095],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99789226,0.00009603972,0.000591091,0.0006726256,0.00028258123,0.00046542904],"domain_scores_gemma":[0.9983493,0.00002661986,0.00029223034,0.0008766998,0.000032484553,0.0004226349],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018141682,0.00038938428,0.001323115,0.00038358785,0.00033022932,0.0000128751135,0.000138496,0.00015062872,0.000016720975],"category_scores_gemma":[0.0000064981296,0.00029951183,0.0008425796,0.0007279155,0.000101286605,0.00002580482,0.00011386843,0.0004165544,0.000025438965],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000030617603,0.000072463525,0.00000966725,0.009592803,0.00007658567,0.000014974276,0.000018110759,2.6488166e-7,1.5075389e-9,0.00076133525,0.004454283,0.98499644],"study_design_scores_gemma":[0.00040011163,0.00023812712,0.00009459866,0.0059714406,0.00066592835,0.000040052557,0.00001975275,0.0000070442984,3.4294644e-8,0.00018702153,0.99212855,0.0002473099],"about_ca_topic_score_codex":0.000048712274,"about_ca_topic_score_gemma":0.000003047666,"teacher_disagreement_score":0.9876743,"about_ca_system_score_codex":0.000091539034,"about_ca_system_score_gemma":0.00012807865,"threshold_uncertainty_score":0.9999457},"labels":[],"label_agreement":null},{"id":"W1987145604","doi":"10.2147/vhrm.2008.04.01.213","title":"Effect of short-term lycopene supplementation and postprandial dyslipidemia on plasma antioxidants and biomarkers of endothelial health in young, healthy individuals","year":2008,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Antioxidant Activity and Oxidative Stress","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"University of Waterloo; Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation of Canada","keywords":"Lycopene; Oxidative stress; Internal medicine; Medicine; Endocrinology; Malondialdehyde; Postprandial; Dyslipidemia; Nitric oxide; Antioxidant; Biochemistry; Chemistry; Obesity","score_opus":0.013477567764619074,"score_gpt":0.3068498764235746,"score_spread":0.2933723086589555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987145604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932888,0.003667665,0.00012051754,0.00038947203,0.00008652214,0.0021051255,0.0001947712,0.000012816747,0.00013427009],"genre_scores_gemma":[0.8646828,0.13437183,0.0005928628,0.00018293915,0.000029365938,0.000023929146,0.000091893846,0.000015002463,0.000009384761],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975687,0.0006431355,0.00064206327,0.00041379462,0.0003530957,0.00037918033],"domain_scores_gemma":[0.99896944,0.00017415313,0.0003409365,0.00019589897,0.000021940199,0.00029761562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017885056,0.00022634746,0.00079913577,0.00044140144,0.00020416561,0.0000072874227,0.0000486859,0.000069203146,0.000008237486],"category_scores_gemma":[0.00004661289,0.00018572246,0.000068778994,0.00020985419,0.000194653,0.00010197706,0.000068943984,0.0001770953,5.9423877e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036189943,0.00024108368,0.86112875,0.0034236826,0.000325083,0.000012656372,0.0011871068,0.0000025080326,0.0000718407,0.00011771887,0.00013682408,0.12973373],"study_design_scores_gemma":[0.0121277245,0.010179857,0.974563,0.00077206554,0.000113254646,0.000031067804,0.00039469352,0.000094162104,0.0010233885,0.000012815779,0.0005340221,0.00015396372],"about_ca_topic_score_codex":0.0015901702,"about_ca_topic_score_gemma":0.00036423755,"teacher_disagreement_score":0.13070416,"about_ca_system_score_codex":0.00006787,"about_ca_system_score_gemma":0.00009504,"threshold_uncertainty_score":0.7573542},"labels":[],"label_agreement":null},{"id":"W1999597525","doi":"10.2147/vhrm.1.1.29.58937","title":"Ongoing clinical trials of the pleiotropic effects of statins","year":2005,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Montreal Clinical Research Institute","funders":"AstraZeneca; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Clinical trial; Tolerability; Statin; Stroke (engine); Internal medicine; Randomized controlled trial; Physical therapy; Disease; Atorvastatin; Bioinformatics; Intensive care medicine; Adverse effect","score_opus":0.08106946811989335,"score_gpt":0.43532799523453297,"score_spread":0.3542585271146396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999597525","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018710851,0.99054813,0.0006150669,0.000050395804,0.0004768668,0.007907698,0.000032720818,0.00001916682,0.00016281405],"genre_scores_gemma":[0.000010324542,0.9966719,0.0022612466,0.00021722667,0.00050516933,0.00014928225,0.000031957807,0.000049586946,0.00010327542],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99024534,0.0047911545,0.0031860874,0.0005235702,0.00083896663,0.00041486195],"domain_scores_gemma":[0.9950566,0.0005860937,0.0024255356,0.0014644545,0.00006221151,0.00040506042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0128738135,0.00037406397,0.0057256003,0.00022107863,0.00014254171,0.000009376674,0.00021092233,0.00025036262,0.000010639853],"category_scores_gemma":[0.00092037645,0.00019917866,0.0035661587,0.000382261,0.00011524442,0.000020073778,0.00021642666,0.00064812397,0.0000051293855],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011403628,0.0001446668,0.00013121631,0.17829368,0.0029483894,0.0000049740474,0.00004592524,7.1869243e-7,2.2544981e-9,0.00027598705,0.0003155212,0.8178275],"study_design_scores_gemma":[0.0022366252,0.0004467905,0.0009377206,0.027516289,0.00758908,0.0000076164424,0.00003758789,0.0000059944537,2.4682504e-7,0.00001749836,0.96106666,0.0001378701],"about_ca_topic_score_codex":0.0004048775,"about_ca_topic_score_gemma":0.00002812403,"teacher_disagreement_score":0.9607512,"about_ca_system_score_codex":0.00011741983,"about_ca_system_score_gemma":0.00081386865,"threshold_uncertainty_score":0.812227},"labels":[],"label_agreement":null},{"id":"W2007918875","doi":"10.2147/vhrm.2006.2.3.263","title":"Beneficial effect of low ethanol intake on the cardiovascular system: possible biochemical mechanisms","year":2006,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Health Sciences Centre; Memorial University of Newfoundland","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Internal medicine; Pharmacology; Cardiology; Physiology","score_opus":0.03961851808375531,"score_gpt":0.3338908191304285,"score_spread":0.2942723010466732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007918875","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030727274,0.9898747,0.0006264975,0.000049099515,0.00039141634,0.008006721,0.000040212217,0.00009808765,0.00060594955],"genre_scores_gemma":[0.00019019573,0.998246,0.00020608082,0.00023569765,0.0002250161,0.0005837297,0.00017733466,0.00007856347,0.00005737271],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953087,0.0013781318,0.001002273,0.00076692965,0.0009319566,0.00061199313],"domain_scores_gemma":[0.9974178,0.00028945555,0.0005601312,0.001253468,0.000050800292,0.0004283089],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0037894635,0.00061078457,0.003155608,0.00041929947,0.0003400542,0.000023775461,0.00020959225,0.00039805105,0.0000118081225],"category_scores_gemma":[0.00006216738,0.00034398527,0.0016874699,0.00042674463,0.00008101453,0.000015648124,0.00013731906,0.0007795253,0.00007733446],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005297398,0.00006857062,0.000014031898,0.36298478,0.0020237998,0.000029692748,0.000018674826,0.0000037447328,4.506734e-8,0.0018720538,0.00082556694,0.63210607],"study_design_scores_gemma":[0.0020482535,0.0011129646,0.000055732293,0.04745026,0.00747496,0.00005382647,0.00003399575,0.00005785129,0.000009417197,0.000015748496,0.9413354,0.00035158757],"about_ca_topic_score_codex":0.000393731,"about_ca_topic_score_gemma":0.0000034884658,"teacher_disagreement_score":0.94050986,"about_ca_system_score_codex":0.00036678466,"about_ca_system_score_gemma":0.00026382442,"threshold_uncertainty_score":0.99990124},"labels":[],"label_agreement":null},{"id":"W2014343126","doi":"10.2147/vhrm.s11253","title":"Stentless aortic valve replacement: an update","year":2011,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Aortic valve replacement; Stent; Regurgitation (circulation); Surgery; Aortic valve; Hemodynamics; Randomized controlled trial; Cardiology; Internal medicine; Stenosis","score_opus":0.03258200838865432,"score_gpt":0.37276786229015624,"score_spread":0.3401858539015019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014343126","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000119044154,0.99470115,0.00006657298,0.000006797754,0.00028821727,0.003641762,0.00011002844,0.0000834109,0.0009829978],"genre_scores_gemma":[0.000010252713,0.9969926,0.00039272197,0.00033093727,0.00012494576,0.00037413696,0.0013350148,0.00008937902,0.00035004874],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971331,0.0003246966,0.0007090178,0.00088314683,0.00036623696,0.0005837996],"domain_scores_gemma":[0.99716526,0.000012012967,0.00044316598,0.0012330792,0.000037595324,0.0011088895],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005105678,0.0005366506,0.0018702374,0.00029077192,0.000242968,0.000043708802,0.0001189254,0.00013289823,0.00009167435],"category_scores_gemma":[0.000007479831,0.00038568105,0.0027327114,0.00021947752,0.00004126798,0.000057725745,0.00016966986,0.00025400447,0.00018394455],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036784328,0.00038518957,0.0017520579,0.041076023,0.009420319,0.000015464298,0.000050364764,9.334335e-8,2.9871154e-11,0.00042264943,0.0005814071,0.9462596],"study_design_scores_gemma":[0.0014642582,0.0004675587,0.0014687604,0.0056140213,0.023046624,0.000008018302,0.0001154841,0.000004011578,2.3976539e-9,0.00005067242,0.96746206,0.00029850472],"about_ca_topic_score_codex":0.00036806584,"about_ca_topic_score_gemma":0.0000055273786,"teacher_disagreement_score":0.9668807,"about_ca_system_score_codex":0.00021265853,"about_ca_system_score_gemma":0.0002072571,"threshold_uncertainty_score":0.9998595},"labels":[],"label_agreement":null},{"id":"W2014582235","doi":"10.2147/vhrm.s63298","title":"XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillation","year":2014,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Bayer HealthCare","keywords":"Medicine; Atrial fibrillation; Rivaroxaban; Stroke (engine); Internal medicine; Cardiology; Intensive care medicine; Warfarin","score_opus":0.03365606308901662,"score_gpt":0.30872252529651045,"score_spread":0.2750664622074938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014582235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93301606,0.0008943835,0.0612881,0.00008554829,0.00004310777,0.004648318,0.0000081640965,0.0000039053516,0.000012382246],"genre_scores_gemma":[0.99512166,0.0011163707,0.0035814221,0.0000069061966,0.000057860478,0.0000070586248,0.000031467152,0.0000062231766,0.000071027236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897283,0.00014201472,0.00041299415,0.00013089512,0.00026324313,0.00007801779],"domain_scores_gemma":[0.99928147,0.00013946075,0.00035663028,0.00012424987,0.000067676665,0.00003048704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009370108,0.000068530324,0.00025108954,0.0001407188,0.000054831595,0.0000041104827,0.000025306077,0.000017056753,0.000003999822],"category_scores_gemma":[0.000047051817,0.000044572254,0.00008291984,0.000099786615,0.000026078278,0.000042899766,0.000028522316,0.00002429058,7.3043545e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014894535,0.00006295225,0.94664896,0.0007077829,0.0004931375,3.3285584e-8,0.0003729776,0.0048834295,5.1971386e-7,0.0010792471,0.000017526227,0.044243984],"study_design_scores_gemma":[0.013533356,0.003591752,0.972997,0.00013814507,0.00038967747,6.350889e-8,0.0005913072,0.007408972,0.0000030163396,0.0002191424,0.0010816578,0.000045887504],"about_ca_topic_score_codex":0.00008486193,"about_ca_topic_score_gemma":0.00003069947,"teacher_disagreement_score":0.062105574,"about_ca_system_score_codex":0.000012991042,"about_ca_system_score_gemma":0.000017863777,"threshold_uncertainty_score":0.18176037},"labels":[],"label_agreement":null},{"id":"W2019882954","doi":"10.2147/vhrm.1.1.41.58936","title":"New anticoagulants for the prevention and treatment of venous thromboembolism","year":2005,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Medicine; Antithrombotic; Intensive care medicine; Venous thromboembolism; Anticoagulant; Anticoagulant therapy; Vitamin K antagonist; Vitamin k; Warfarin; Thrombosis; Surgery; Atrial fibrillation; Internal medicine","score_opus":0.052950610041974704,"score_gpt":0.36858380623860393,"score_spread":0.3156331961966292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019882954","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045489836,0.9889747,0.0016018546,0.00016433383,0.00022390424,0.008759596,0.000031122498,0.00003167993,0.00016735561],"genre_scores_gemma":[0.0000074951226,0.9945496,0.0036807866,0.00011414816,0.00037671358,0.0004710554,0.0001083362,0.000058862282,0.0006330069],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978582,0.00012212335,0.0007345306,0.00055705983,0.0002861024,0.00044194396],"domain_scores_gemma":[0.99834067,0.00010765299,0.0005499789,0.00064677704,0.000028269966,0.00032663776],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049629254,0.00043909933,0.002859776,0.00022581125,0.00029315206,0.00003564813,0.000110685,0.00012976766,0.000019947038],"category_scores_gemma":[0.000010811843,0.00025734532,0.0005857169,0.00016258727,0.000055177778,0.00003353857,0.0000960239,0.000104896186,0.0000078010435],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000132592295,0.0006388996,0.000017291393,0.02239046,0.0041332915,0.0000035106816,0.0002714078,0.0000018842961,2.3583373e-9,0.0011822125,0.0025180988,0.9688297],"study_design_scores_gemma":[0.0016795049,0.0014663849,0.000834405,0.004775869,0.013788169,0.000012595342,0.00013304137,0.000029674355,8.0325954e-8,0.00011513711,0.9769692,0.00019596431],"about_ca_topic_score_codex":0.0007171851,"about_ca_topic_score_gemma":0.00008627641,"teacher_disagreement_score":0.97445107,"about_ca_system_score_codex":0.00015079652,"about_ca_system_score_gemma":0.0002465211,"threshold_uncertainty_score":0.9999879},"labels":[],"label_agreement":null},{"id":"W2027200715","doi":"10.2147/vhrm.s54714","title":"Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty","year":2014,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"Bayer HealthCare; Janssen Scientific Affairs","keywords":"Medicine; Rivaroxaban; Number needed to harm; Pulmonary embolism; Deep vein; Number needed to treat; Adverse effect; Placebo; Anesthesia; Surgery; Thrombosis; Relative risk; Internal medicine; Warfarin; Confidence interval; Atrial fibrillation","score_opus":0.019149418282129134,"score_gpt":0.30791315503027317,"score_spread":0.28876373674814404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027200715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94897443,0.008618759,0.033283997,0.000448037,0.0012878319,0.006207545,0.000077732766,0.00006510522,0.0010365343],"genre_scores_gemma":[0.9087119,0.07797281,0.011588832,0.00025264762,0.00027680962,0.00072115316,0.00007172156,0.00005624037,0.000347881],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974972,0.00018120217,0.0007435882,0.00050340715,0.00055909244,0.00051548897],"domain_scores_gemma":[0.99796104,0.00023268179,0.00059431535,0.0008526852,0.000115035036,0.0002442143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016107297,0.00029543767,0.0009939215,0.00018852408,0.0003241207,0.000027387538,0.00011465057,0.00008816468,0.00008256798],"category_scores_gemma":[0.000080175094,0.00019461135,0.00035050185,0.00021362529,0.00012526073,0.00007195301,0.00020868935,0.0001966607,0.000005538493],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016733515,0.0037811832,0.017238712,0.0066509857,0.0059623723,0.0000042223674,0.0018488378,0.0014107116,0.0000046897503,0.014182047,0.00277488,0.944468],"study_design_scores_gemma":[0.010383662,0.0071985796,0.76965237,0.0005657235,0.0037163452,0.0000039746974,0.0010371953,0.0021685292,0.000018472028,0.0011515429,0.20376849,0.00033513372],"about_ca_topic_score_codex":0.0008957237,"about_ca_topic_score_gemma":0.00049968855,"teacher_disagreement_score":0.94413286,"about_ca_system_score_codex":0.00009802628,"about_ca_system_score_gemma":0.00010584569,"threshold_uncertainty_score":0.79360205},"labels":[],"label_agreement":null},{"id":"W2041269545","doi":"10.2147/vhrm.s29144","title":"Endoglin: a critical mediator of cardiovascular health","year":2013,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Vascular Anomalies and Treatments","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Heart and Stroke Foundation; University of Toronto","funders":"National Heart, Lung, and Blood Institute","keywords":"Endoglin; Medicine; Disease; Mediator; Cardiac fibrosis; SUPERFAMILY; Transforming growth factor; Transforming growth factor beta; Fibrosis; Bioinformatics; Receptor; Internal medicine; Genetics; Biology","score_opus":0.03946597628389597,"score_gpt":0.34924582665145665,"score_spread":0.30977985036756067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041269545","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008565924,0.9932614,0.0008479002,0.00011357471,0.00030286828,0.0049671438,0.00008807142,0.00006368307,0.00034677843],"genre_scores_gemma":[0.0000032614253,0.99343187,0.0049909945,0.00023762131,0.0001971986,0.00052809366,0.0003074792,0.00010457763,0.00019893647],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952428,0.0006965407,0.0013562563,0.0009196464,0.0009288407,0.00085595745],"domain_scores_gemma":[0.99662966,0.00009054049,0.000480221,0.001451463,0.0000872077,0.0012608927],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012913732,0.0006650767,0.004774255,0.00043923873,0.00026630535,0.000031572134,0.00017656265,0.00024242797,0.000066988185],"category_scores_gemma":[0.000076435215,0.00046708286,0.002890709,0.00036742166,0.00014237706,0.000052258256,0.00022839304,0.00046086893,0.000099015946],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000053313343,0.00024707132,0.00004734794,0.13411012,0.011603519,0.000058028952,0.00007440278,6.380342e-7,1.8156113e-10,0.0005885995,0.0010373103,0.8522276],"study_design_scores_gemma":[0.0015887243,0.0006247657,0.000024313622,0.01048643,0.008701376,0.00008740154,0.00014309915,0.000009693497,4.4146912e-8,0.00003084944,0.9780182,0.00028510301],"about_ca_topic_score_codex":0.0014497972,"about_ca_topic_score_gemma":0.000007558911,"teacher_disagreement_score":0.97698087,"about_ca_system_score_codex":0.0002845391,"about_ca_system_score_gemma":0.000653319,"threshold_uncertainty_score":0.9997781},"labels":[],"label_agreement":null},{"id":"W2042361694","doi":"10.2147/vhrm.s57116","title":"Pantethine, a derivative of vitamin B5, favorably alters total, LDL and non-HDL cholesterol in low to moderate cardiovascular risk subjects eligible for statin therapy: a triple-blinded placebo and diet-controlled investigation","year":2014,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Neurological diseases and metabolism","field":"Neuroscience","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"KGK Synergize (Canada)","funders":"","keywords":"Medicine; Placebo; Internal medicine; Homocysteine; Statin; Population; Cholesterol; Gastroenterology; Placebo-controlled study; Endocrinology","score_opus":0.020686356380752183,"score_gpt":0.26737301043679246,"score_spread":0.2466866540560403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042361694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9746464,0.0032819968,0.016525649,0.00023528363,0.00008378626,0.0051259142,0.00005722558,0.000025608124,0.000018177017],"genre_scores_gemma":[0.93715703,0.058490887,0.0011886957,0.0024576918,0.000026855194,0.0006292329,0.000006468989,0.000024779496,0.000018350944],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99696887,0.00095194444,0.00050326134,0.0007756152,0.00033546516,0.00046486675],"domain_scores_gemma":[0.99858546,0.00028471003,0.00026299842,0.0003357267,0.000041612137,0.00048946514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016185262,0.00027916025,0.00080515124,0.0003140496,0.0002559097,0.000087283486,0.00010438834,0.000061549596,6.378752e-7],"category_scores_gemma":[0.00057357043,0.0002122578,0.00017066672,0.00034971128,0.00010307488,0.00013535502,0.00009699144,0.00016521093,5.7528354e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057017535,0.0013918065,0.016466813,0.0067162286,0.001864503,0.00003871322,0.016702075,0.044396076,0.004575885,0.0034509443,0.00042745876,0.84695196],"study_design_scores_gemma":[0.2629043,0.012377333,0.38360685,0.0008887021,0.0011923224,0.000008370745,0.0016645906,0.30317917,0.00903967,0.012555125,0.010423303,0.0021602449],"about_ca_topic_score_codex":0.000705645,"about_ca_topic_score_gemma":0.000056103072,"teacher_disagreement_score":0.8447917,"about_ca_system_score_codex":0.000019131561,"about_ca_system_score_gemma":0.000047216283,"threshold_uncertainty_score":0.8655622},"labels":[],"label_agreement":null},{"id":"W2048382309","doi":"10.2147/vhrm.s50464","title":"Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study","year":2013,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"","keywords":"Bioavailability; Medicine; Eicosapentaenoic acid; Pharmacokinetics; Dosing; Docosahexaenoic acid; Fatty acid; Omega 3 fatty acid; Pharmacology; Internal medicine; Biochemistry; Chemistry; Polyunsaturated fatty acid","score_opus":0.022459342694400225,"score_gpt":0.28002422180640146,"score_spread":0.2575648791120012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048382309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98657084,0.0003805991,0.0025692496,0.0012419306,0.00009584258,0.008940972,0.000049673177,0.00006603914,0.00008486685],"genre_scores_gemma":[0.99541414,0.0006117676,0.0027474193,0.0006369507,0.00008106795,0.0003778992,0.00006608558,0.000035918354,0.000028781531],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99649554,0.0006571622,0.00063643797,0.0006694485,0.0008455038,0.00069587573],"domain_scores_gemma":[0.9975808,0.00006367598,0.00041729145,0.001275104,0.00022871542,0.00043439717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014637334,0.00031885566,0.00045334728,0.00020934887,0.0010620306,0.00013628443,0.00028506966,0.00006203435,0.00002475115],"category_scores_gemma":[0.000024393534,0.00018191694,0.0000746006,0.00038820284,0.00011713862,0.00052752846,0.00013589059,0.00037095786,0.000008001771],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06753709,0.01383699,0.37105379,0.01284362,0.0026238458,0.000015427528,0.15950184,0.0040558246,0.00061125925,0.00072156766,0.0053146295,0.36188415],"study_design_scores_gemma":[0.021011692,0.061039124,0.8245619,0.0005345109,0.00031983838,0.0000022026923,0.022730967,0.06423199,0.00096582243,0.0018199709,0.0020271023,0.00075490656],"about_ca_topic_score_codex":0.0056661367,"about_ca_topic_score_gemma":0.0041550174,"teacher_disagreement_score":0.4535081,"about_ca_system_score_codex":0.00018649071,"about_ca_system_score_gemma":0.00006453299,"threshold_uncertainty_score":0.8565542},"labels":[],"label_agreement":null},{"id":"W2054533416","doi":"10.2147/vhrm.2005.1.4.261","title":"Corticosteroids and endothelial dysfunction","year":2005,"lang":"en","type":"letter","venue":"Vascular Health and Risk Management","topic":"Adrenal Hormones and Disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Endothelial dysfunction; Intensive care medicine; Internal medicine","score_opus":0.009324793667004316,"score_gpt":0.24234658374507473,"score_spread":0.23302179007807042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054533416","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013743943,0.38013878,0.004956396,0.5857776,0.0011052561,0.005460032,0.00010456761,0.00029076586,0.0084226625],"genre_scores_gemma":[0.00024189045,0.4737697,0.0009422148,0.51971614,0.0016157782,0.000052234613,0.00029003827,0.000048744183,0.0033232777],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99841857,0.00006872782,0.00031681545,0.00044951445,0.00034489357,0.00040148414],"domain_scores_gemma":[0.99924564,0.000016440097,0.0001570152,0.00031227234,0.000020836893,0.00024779062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019883523,0.0002578975,0.00043559005,0.0001811768,0.00018613545,0.00003074207,0.000038444712,0.00021732651,0.000034910838],"category_scores_gemma":[0.000008149514,0.00020161469,0.000113869406,0.000071357885,0.00005766535,0.00003462064,0.00007250257,0.00063195487,0.000025865604],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008116275,0.000039787177,0.0012840175,0.0018427819,0.00039142024,0.00011833747,0.00009908084,0.0000012522839,7.411812e-8,0.000039349616,0.45935547,0.5367473],"study_design_scores_gemma":[0.0023092313,0.00048461393,0.003888811,0.00015250959,0.0005001775,0.00004216834,0.00013270367,0.00010162608,1.5327159e-7,0.00007498948,0.99213517,0.00017785546],"about_ca_topic_score_codex":0.0004018971,"about_ca_topic_score_gemma":0.000021400207,"teacher_disagreement_score":0.5365694,"about_ca_system_score_codex":0.000065792374,"about_ca_system_score_gemma":0.000045304445,"threshold_uncertainty_score":0.82216084},"labels":[],"label_agreement":null},{"id":"W2056362163","doi":"10.2147/vhrm.2006.2.2.125","title":"Valsartan in the treatment of heart attack survivors","year":2006,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Health Sciences Centre","funders":"Heart and Stroke Foundation of Canada","keywords":"Medicine; Valsartan; Cardiology; Heart failure; Internal medicine; ACE inhibitor; Myocardial infarction; Atrial fibrillation; Angiotensin II; Angiotensin II receptor type 1; Left ventricular hypertrophy; Angiotensin-converting enzyme; Blood pressure","score_opus":0.04892616212015362,"score_gpt":0.3608771020874571,"score_spread":0.3119509399673035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056362163","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015360977,0.99195004,0.000020904536,0.0004321436,0.00011367729,0.006146823,0.00002024387,0.000030231518,0.0011323486],"genre_scores_gemma":[0.0000063738034,0.9968327,0.0011843798,0.00018213739,0.0001014391,0.00034702892,0.00030289468,0.00004203926,0.0010009861],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99693495,0.0006053724,0.0009227836,0.0005508398,0.00046464737,0.0005213998],"domain_scores_gemma":[0.9985148,0.0001018575,0.00030161458,0.0008687705,0.00001822037,0.00019476973],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009523248,0.0004998651,0.002275425,0.0004625578,0.00013241614,0.000024188757,0.00011659045,0.00012722718,0.00001570403],"category_scores_gemma":[0.0000049805167,0.00027069106,0.000707131,0.0005087436,0.000060446422,0.000025642083,0.000041636697,0.00016788646,0.000034867102],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011387411,0.0011159249,0.0009726374,0.026222702,0.00088735495,0.00006570232,0.0003119052,0.0000021580477,3.4576825e-10,0.00025373837,0.007869252,0.96228725],"study_design_scores_gemma":[0.0013845637,0.0010792634,0.0005587732,0.0031620876,0.0025261992,0.000010863388,0.00024196417,0.000006027658,1.5836239e-8,0.000013063134,0.9908351,0.00018212607],"about_ca_topic_score_codex":0.0035149718,"about_ca_topic_score_gemma":0.00091325457,"teacher_disagreement_score":0.9829658,"about_ca_system_score_codex":0.0002742057,"about_ca_system_score_gemma":0.00012929791,"threshold_uncertainty_score":0.99997455},"labels":[],"label_agreement":null},{"id":"W2057146024","doi":"10.2147/vhrm.s61966","title":"Vascular quality of care pilot study: how admission to a vascular surgery service affects evidence-based pharmacologic risk factor modification in patients with lower extremity peripheral arterial disease","year":2014,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Island Health; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Guideline; Statin; ACE inhibitor; Medical prescription; Vascular disease; Population; Vascular surgery; Internal medicine; Physical therapy; Intensive care medicine; Emergency medicine; Angiotensin-converting enzyme; Blood pressure; Pharmacology; Cardiac surgery","score_opus":0.04049451421858204,"score_gpt":0.3058371728529314,"score_spread":0.26534265863434936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057146024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876707,0.002158357,0.0025381288,0.00049635035,0.00019601366,0.0067923856,0.000051841256,0.00008913756,0.0000070891015],"genre_scores_gemma":[0.9951691,0.0022994685,0.0005203989,0.0012851451,0.00007621427,0.00047784322,0.0001198514,0.00004288249,0.000009107232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99453115,0.0019617302,0.0006096703,0.0010320189,0.0012708849,0.0005945372],"domain_scores_gemma":[0.9969554,0.000102523874,0.00044692509,0.0010823577,0.0002322267,0.0011805678],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016753271,0.0004565549,0.0009389322,0.00035688755,0.00024965894,0.00006424439,0.00019062866,0.00004588712,0.000060771654],"category_scores_gemma":[0.00021664884,0.00034944684,0.00023299266,0.0005957301,0.000043655982,0.00022099703,0.00015814834,0.00020994508,0.000005232597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007187002,0.0038417631,0.9355846,0.0053284643,0.00046717768,0.0000123834825,0.0006750997,0.0017330276,0.0000088055795,0.0000041800363,0.00010841271,0.045049064],"study_design_scores_gemma":[0.009145926,0.0028214494,0.9818283,0.00084587344,0.00068975985,3.2729357e-8,0.0005247697,0.0019631453,0.0000029345936,0.000005263627,0.0018016937,0.0003708884],"about_ca_topic_score_codex":0.0012791866,"about_ca_topic_score_gemma":0.0003809496,"teacher_disagreement_score":0.046243645,"about_ca_system_score_codex":0.00043930567,"about_ca_system_score_gemma":0.000192788,"threshold_uncertainty_score":0.99989575},"labels":[],"label_agreement":null},{"id":"W2063979477","doi":"10.2147/vhrm.2006.2.3.285","title":"Metabolic syndrome: the danger signal in atherosclerosis","year":2006,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Canadian Institutes of Health Research; Sanofi","keywords":"Medicine; Metabolic syndrome; Adipokine; Inflammation; Immune system; Adipose tissue; Pathophysiology; Immunology; Disease; Innate immune system; Bioinformatics; Internal medicine; Endocrinology; Diabetes mellitus; Insulin resistance; Biology","score_opus":0.02467027535985939,"score_gpt":0.29557234694411816,"score_spread":0.2709020715842588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063979477","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021339396,0.9955291,0.000115870804,0.00005776486,0.00015445155,0.0031330646,0.000042121606,0.000049088023,0.0007051525],"genre_scores_gemma":[0.000008493946,0.99718714,0.00028581635,0.00037519803,0.00022651796,0.00054137246,0.0002575651,0.00005726797,0.0010606279],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972659,0.0004270017,0.0008443975,0.00050464226,0.00045636055,0.0005017147],"domain_scores_gemma":[0.9985421,0.000054534554,0.00040064234,0.00065616576,0.00002760335,0.0003190023],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010281218,0.00042932082,0.0017668657,0.0003798763,0.00022626261,0.00004259936,0.00017413912,0.00013023219,0.00004616629],"category_scores_gemma":[0.00001920897,0.0002473031,0.000540799,0.0005538181,0.00007897541,0.000048245623,0.000094941555,0.0003349651,0.000047655783],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004251044,0.00011698473,0.00031575508,0.018407566,0.00061883713,0.000024710791,0.00006278674,0.0000042303964,1.0980628e-9,0.0005473043,0.0013268697,0.9785707],"study_design_scores_gemma":[0.0007864715,0.00004529919,0.0074626147,0.004505241,0.0037777596,0.000029306555,0.000051636634,0.000012074682,1.1184971e-8,0.000037638754,0.983078,0.00021395678],"about_ca_topic_score_codex":0.00090816617,"about_ca_topic_score_gemma":0.00007305333,"teacher_disagreement_score":0.98175114,"about_ca_system_score_codex":0.000077799865,"about_ca_system_score_gemma":0.00025526455,"threshold_uncertainty_score":0.9999979},"labels":[],"label_agreement":null},{"id":"W2072285004","doi":"10.2147/vhrm.s6668","title":"Optimal use of β-blockers in high-risk hypertension: A guide to dosing equivalence","year":2010,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McGill University; GlaxoSmithKline; American Diabetes Association","keywords":"Medicine; Dosing; Regimen; Diabetes mellitus; Blood pressure; Intensive care medicine; Disease; BETA (programming language); Drug class; Internal medicine; Pharmacology; Drug; Endocrinology","score_opus":0.06937492799736371,"score_gpt":0.3418635859320006,"score_spread":0.2724886579346369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072285004","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007988464,0.99547595,0.00024060172,0.0003988237,0.00033084617,0.0026159354,0.000046966645,0.000042064825,0.000049969545],"genre_scores_gemma":[0.0000045783786,0.9364543,0.061494116,0.0012880198,0.00013462554,0.00010428947,0.000049475737,0.000055640226,0.00041495773],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964316,0.00033997407,0.0012162757,0.00082663633,0.00057106605,0.00061447406],"domain_scores_gemma":[0.9975548,0.00018789544,0.0005471466,0.0010404343,0.0001345929,0.00053516944],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001240237,0.00051331,0.0033402918,0.00065983826,0.00022461843,0.000030908308,0.00016064644,0.00026738484,0.000013712166],"category_scores_gemma":[0.00013687293,0.00036173267,0.00045584046,0.00053952495,0.00009119793,0.00005862927,0.00046544004,0.00082227355,0.000032028423],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042625084,0.00015165804,0.00041589537,0.02177528,0.0013469292,0.00009580813,0.00013503342,0.000012473399,7.9028304e-8,0.000041747535,0.027301619,0.9486809],"study_design_scores_gemma":[0.0010881816,0.00022225369,0.0003499261,0.015081877,0.007036154,0.000048872156,0.000080823804,0.000011681536,1.8035657e-7,0.0000033891347,0.9757711,0.0003055416],"about_ca_topic_score_codex":0.0038784705,"about_ca_topic_score_gemma":0.0002962632,"teacher_disagreement_score":0.9484695,"about_ca_system_score_codex":0.00004276056,"about_ca_system_score_gemma":0.00018917311,"threshold_uncertainty_score":0.9998835},"labels":[],"label_agreement":null},{"id":"W2072298699","doi":"10.2147/vhrm.2006.2.3.221","title":"Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease","year":2006,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"","keywords":"Medicine; Atrial fibrillation; Disease; C-reactive protein; Heart failure; Cardiology; Internal medicine; Pathophysiology; Inflammation; Myocarditis; Intensive care medicine; Systemic inflammation","score_opus":0.022041387707686252,"score_gpt":0.34479521992897977,"score_spread":0.3227538322212935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072298699","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000078961784,0.9928972,0.0018308857,0.000081314865,0.00019398877,0.003952483,0.00015950053,0.000030695614,0.0007749395],"genre_scores_gemma":[0.000092273935,0.9982994,0.0004652187,0.000028095725,0.00037905737,0.0003559285,0.0002299776,0.00004825176,0.00010174778],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967709,0.00052757893,0.00097623613,0.00050510425,0.0008239106,0.00039627816],"domain_scores_gemma":[0.9977014,0.00015751166,0.00047276152,0.0011523393,0.000096395175,0.00041959205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009814037,0.00039966794,0.0021908488,0.00021195316,0.0001539567,0.000014524041,0.00017149058,0.00009914393,0.000011747962],"category_scores_gemma":[0.00032024313,0.00023842428,0.0016007941,0.00032487247,0.00030301238,0.000057539804,0.0001088965,0.00026192112,0.0000056305244],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005182201,0.00033530107,0.00007000029,0.1331265,0.005600949,0.000029260462,0.000097616714,0.000019615127,4.525588e-9,0.009911746,0.00031971486,0.85043746],"study_design_scores_gemma":[0.00068867364,0.00009772731,0.00055812445,0.006133807,0.017659051,0.0000054817656,0.000105329884,0.00001570286,3.62651e-7,0.00024056017,0.97430867,0.00018648744],"about_ca_topic_score_codex":0.0010376819,"about_ca_topic_score_gemma":0.000005643809,"teacher_disagreement_score":0.97398895,"about_ca_system_score_codex":0.000055996996,"about_ca_system_score_gemma":0.00054169993,"threshold_uncertainty_score":0.97226596},"labels":[],"label_agreement":null},{"id":"W2075102176","doi":"10.2147/vhrm.2006.2.4.379","title":"Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI)","year":2006,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research; Hamilton Health Sciences; Sanofi; McMaster University; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Clopidogrel; Cardiology; Percutaneous coronary intervention; Internal medicine; Myocardial infarction; Aspirin; Thrombus; Ticlopidine","score_opus":0.06356072955798536,"score_gpt":0.3606762692281438,"score_spread":0.2971155396701584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075102176","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011058111,0.9932528,0.000942724,0.00007341537,0.00026503185,0.004131189,0.00015882464,0.000025031015,0.000045170353],"genre_scores_gemma":[0.00007800522,0.9981618,0.0002753325,0.00028484524,0.00022049721,0.00018945531,0.0006580533,0.00004857721,0.00008343912],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960969,0.0011474276,0.0013151347,0.00052114413,0.0006116864,0.00030771724],"domain_scores_gemma":[0.9977231,0.00015859857,0.0009137412,0.0009551499,0.00006785138,0.00018156922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00111249,0.00043465398,0.0021978084,0.00023064711,0.0001507641,0.000019817144,0.00009660901,0.00020239591,0.000015351861],"category_scores_gemma":[0.000009206246,0.0002423545,0.00230011,0.00028463057,0.00012595141,0.000038698112,0.00004094525,0.0002154315,0.000009703331],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017947305,0.00053384155,0.0009101582,0.0055612037,0.019773412,0.0000100121915,0.000026029205,0.000013543095,7.398562e-9,0.00043806416,0.00042445137,0.9721298],"study_design_scores_gemma":[0.001860507,0.0015031699,0.0019307912,0.002751993,0.015883232,0.000009292797,0.000030424912,0.000019789328,2.5732567e-7,0.000025008847,0.9758121,0.0001734851],"about_ca_topic_score_codex":0.00013863108,"about_ca_topic_score_gemma":0.0000028806262,"teacher_disagreement_score":0.9753876,"about_ca_system_score_codex":0.00016981854,"about_ca_system_score_gemma":0.00021367396,"threshold_uncertainty_score":0.98829293},"labels":[],"label_agreement":null},{"id":"W2078035712","doi":"10.2147/vhrm.s55246","title":"Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk","year":2014,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Janssen Research and Development; Bayer HealthCare","keywords":"Rivaroxaban; Medicine; Atrial fibrillation; Warfarin; Intensive care medicine; Stroke (engine); Dosing; Dabigatran; Anticoagulant; Apixaban; Edoxaban; Clinical trial; Internal medicine","score_opus":0.05452617617708271,"score_gpt":0.3750624257402439,"score_spread":0.3205362495631612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078035712","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017001416,0.98371387,0.007834282,0.00008992535,0.00024357944,0.00628898,0.000031805583,0.0000397982,0.00005761235],"genre_scores_gemma":[0.000032002055,0.97240996,0.026227472,0.00004836252,0.0009364125,0.000009670748,0.0002021046,0.000057053796,0.00007694432],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99732596,0.00024785718,0.0009098708,0.0006627508,0.00041461346,0.00043896868],"domain_scores_gemma":[0.99807894,0.0002648053,0.0009147932,0.00040274273,0.000060543865,0.00027818928],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001389731,0.0004085934,0.0017321401,0.0003682606,0.00029501732,0.000063634725,0.00005184294,0.00016040879,0.0000051903858],"category_scores_gemma":[0.00018256418,0.00029556378,0.0003745989,0.00029890853,0.00003935343,0.000102615435,0.00012335379,0.00022583909,0.0000032500268],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019784417,0.0000056645335,0.21298645,0.023792163,0.0008348509,0.0000022425247,0.00002933297,0.00008145765,8.6233895e-11,0.0008465462,0.00008727892,0.7611362],"study_design_scores_gemma":[0.0050012385,0.0004012642,0.018315574,0.0055135423,0.0036582819,0.0000026946443,0.00002464776,0.0011698145,2.2276918e-9,0.00005909897,0.9655415,0.00031234368],"about_ca_topic_score_codex":0.00016308192,"about_ca_topic_score_gemma":0.00003551131,"teacher_disagreement_score":0.9654542,"about_ca_system_score_codex":0.00019337499,"about_ca_system_score_gemma":0.000114392795,"threshold_uncertainty_score":0.99994963},"labels":[],"label_agreement":null},{"id":"W2089332819","doi":"10.2147/vhrm.2006.2.4.371","title":"Fondaparinux in the management of patients with ST-elevation acute myocardial infarction","year":2006,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Acute Myocardial Infarction Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Fondaparinux; Medicine; Myocardial infarction; Internal medicine; Percutaneous coronary intervention; Heparin; ST elevation; Cardiology; Placebo; Thrombosis; Venous thromboembolism","score_opus":0.0219480472324214,"score_gpt":0.3284135734351888,"score_spread":0.3064655262027674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089332819","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021004789,0.98753095,0.00054900284,0.00021518454,0.00014529825,0.008863674,0.00008539903,0.000031737676,0.0023687084],"genre_scores_gemma":[0.000015699163,0.99615484,0.0010673279,0.00046883608,0.000083656414,0.0006138252,0.0013899042,0.000044917317,0.00016100098],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964543,0.00050551805,0.00084950274,0.0005443091,0.0011757163,0.00047062765],"domain_scores_gemma":[0.9984496,0.000040656734,0.0005041498,0.0007507993,0.000099583915,0.00015516584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013797905,0.00037344132,0.0012600534,0.00063608633,0.00017478754,0.000035883488,0.00019170993,0.00014504952,0.000009176597],"category_scores_gemma":[0.000004803385,0.0002236428,0.00034256096,0.00097317086,0.00008695447,0.00006901913,0.00016113014,0.0005484834,0.000011663002],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008770546,0.00023892803,0.0021131039,0.024468252,0.0043781935,0.000021355036,0.000065580934,0.0000093526205,2.655861e-10,0.00051790633,0.0045940005,0.9635056],"study_design_scores_gemma":[0.0020443113,0.0004434716,0.023388091,0.0029335213,0.0036198716,0.0000046501605,0.00011979208,0.000010271781,4.401889e-9,0.000024777364,0.9672328,0.00017841738],"about_ca_topic_score_codex":0.0005394758,"about_ca_topic_score_gemma":0.000013585433,"teacher_disagreement_score":0.9633272,"about_ca_system_score_codex":0.00031712174,"about_ca_system_score_gemma":0.00013009096,"threshold_uncertainty_score":0.91198885},"labels":[],"label_agreement":null},{"id":"W2090687235","doi":"10.2147/vhrm.s30064","title":"Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery","year":2012,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Rivaroxaban; Venous thromboembolism; Venous thrombosis; Surgery; Hip surgery; Thrombosis; Arthroplasty; Internal medicine; Warfarin; Atrial fibrillation","score_opus":0.02666006372937954,"score_gpt":0.2790618897759476,"score_spread":0.252401826046568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090687235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9648646,0.02656269,0.0038109655,0.000061994404,0.00011283827,0.004521359,0.000029444423,0.00000943108,0.000026671958],"genre_scores_gemma":[0.98320717,0.012587967,0.0035860124,0.000080233156,0.000054131837,0.00041526678,0.000019271238,0.000019983603,0.000029974532],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983945,0.00015254716,0.00059694145,0.00026095597,0.00031955697,0.00027550777],"domain_scores_gemma":[0.9990082,0.0001291574,0.00033772207,0.00025194205,0.00008479181,0.00018820078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014572121,0.00016006835,0.0008126744,0.0002471304,0.000100700614,0.00000763796,0.000037761776,0.00004349965,0.000019699013],"category_scores_gemma":[0.00003829727,0.00013197474,0.00011761733,0.000115297684,0.000094070136,0.00007849198,0.000102311235,0.00006136877,4.0981686e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001052678,0.020956406,0.6981869,0.03415246,0.0069595403,0.000010555615,0.015004644,0.00008165576,0.00002526636,0.004327492,0.0023891197,0.21685328],"study_design_scores_gemma":[0.0032492531,0.0038230158,0.9866395,0.0004137034,0.0009793643,0.0000036291142,0.0025554476,0.00009860178,0.000042507196,0.0003032614,0.0017491523,0.00014255643],"about_ca_topic_score_codex":0.00040990047,"about_ca_topic_score_gemma":0.000020126085,"teacher_disagreement_score":0.2884526,"about_ca_system_score_codex":0.000023446984,"about_ca_system_score_gemma":0.000040687366,"threshold_uncertainty_score":0.5381774},"labels":[],"label_agreement":null},{"id":"W2092278852","doi":"10.2147/vhrm.1.1.5.58931","title":"Coxibs: can this class of drugs survive?","year":2005,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Class (philosophy); Artificial intelligence","score_opus":0.005923473833793288,"score_gpt":0.24513648772092075,"score_spread":0.23921301388712746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092278852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9607556,0.026915958,0.0002392135,0.001483007,0.0002942395,0.0014627804,0.000013782633,0.00007415582,0.008761269],"genre_scores_gemma":[0.80734664,0.18232329,0.003381842,0.0041633495,0.00051975774,0.000074884025,0.000053187003,0.000051816507,0.0020852177],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986891,0.00012471515,0.00030811795,0.00022788004,0.00033194062,0.0003182553],"domain_scores_gemma":[0.99909526,0.000029857456,0.00013805789,0.00032434808,0.000037433612,0.0003750338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093808165,0.00013538913,0.00035633982,0.00014162053,0.0001170977,0.00000613578,0.00005284112,0.000052636427,0.000059109145],"category_scores_gemma":[0.000018846396,0.00010533001,0.000101870515,0.00013306251,0.000050860235,0.000027536056,0.00004675474,0.00014347325,0.000028153336],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019621351,0.00031715556,0.058170747,0.004917404,0.000738189,0.000035654837,0.0044415887,0.000041780153,0.0000070038536,0.0038202973,0.020502374,0.9068116],"study_design_scores_gemma":[0.0033854535,0.00041777935,0.023758339,0.00024862622,0.00022254956,0.0000047040753,0.00074995164,0.0009180766,0.00015128247,0.00004393069,0.9699334,0.00016592332],"about_ca_topic_score_codex":0.0007884618,"about_ca_topic_score_gemma":0.00016220701,"teacher_disagreement_score":0.949431,"about_ca_system_score_codex":0.00007968657,"about_ca_system_score_gemma":0.00008338736,"threshold_uncertainty_score":0.42952332},"labels":[],"label_agreement":null},{"id":"W2095539779","doi":"10.2147/vhrm.2006.2.2.171","title":"Vascular risks and management of obesity in children and adolescents","year":2006,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Obesity, Physical Activity, Diet","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Obesity; Overweight; Dyslipidemia; Pharmacotherapy; Pediatrics; Metabolic syndrome; Childhood obesity; Disease; Diabetes mellitus; Population; Environmental health; Internal medicine; Endocrinology","score_opus":0.022400975595227347,"score_gpt":0.31225784491910025,"score_spread":0.2898568693238729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095539779","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031135887,0.96358943,0.000040364597,0.000011749739,0.0000513929,0.004890219,0.000042277738,0.000035976525,0.00020273225],"genre_scores_gemma":[0.0029556968,0.9959117,0.0006537173,0.00005873564,0.00007260242,0.000092702925,0.00014511973,0.00005865227,0.00005103456],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99666053,0.0003894914,0.0008103299,0.0009851134,0.0005783228,0.00057618826],"domain_scores_gemma":[0.99832,0.000023400116,0.00046296648,0.0007246709,0.000025836227,0.00044315148],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009313943,0.0005855677,0.0023932813,0.0004375364,0.0001424717,0.000030335043,0.00014728752,0.00020292266,0.000002709557],"category_scores_gemma":[0.0000061763335,0.0004796112,0.00037038443,0.0004090329,0.00013918428,0.00006546144,0.00061796186,0.0005423823,0.0000062408512],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000076348,0.0021650495,0.14019927,0.13395394,0.001323373,0.000027674849,0.000016977769,0.000001042814,8.8146196e-10,0.0003534306,0.00011069385,0.7218409],"study_design_scores_gemma":[0.002337071,0.00020670396,0.75878614,0.021151438,0.003686123,0.00001126135,0.000023225677,0.000015496591,4.399888e-8,0.00017274155,0.21324295,0.00036677945],"about_ca_topic_score_codex":0.0023011528,"about_ca_topic_score_gemma":0.00006912274,"teacher_disagreement_score":0.7214741,"about_ca_system_score_codex":0.00015679629,"about_ca_system_score_gemma":0.00004556481,"threshold_uncertainty_score":0.9997656},"labels":[],"label_agreement":null},{"id":"W2119535512","doi":"10.2147/vhrm.s55298","title":"Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients: results of the POWER survey","year":2014,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital du Saint-Sacrement; Lawson Health Research Institute; Western University","funders":"","keywords":"Medicine; Framingham Risk Score; Blood pressure; Internal medicine; Cohort; Regimen; Cardiology; Framingham Heart Study; Cohort study; Physical therapy; Disease","score_opus":0.024559338107928482,"score_gpt":0.30136413815682805,"score_spread":0.27680480004889957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119535512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793362,0.017548667,0.000035021283,0.00094714895,0.00016500344,0.0016086521,0.00026916774,0.000009083726,0.00008102625],"genre_scores_gemma":[0.9840409,0.008826834,0.00015384155,0.0068283705,0.000009459424,0.000026005084,0.00008431552,0.000015851025,0.000014434257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955487,0.0030605984,0.00040010276,0.00035400223,0.00030630047,0.0003302877],"domain_scores_gemma":[0.9977753,0.0009874741,0.00023007195,0.0005620194,0.00013829953,0.00030681325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038955316,0.00017798875,0.0007564722,0.00016667951,0.00015224973,0.0000040147606,0.00007968912,0.00006687831,0.0000030362155],"category_scores_gemma":[0.0009118778,0.00010340363,0.000115709765,0.00021260614,0.00010224291,0.0000149824755,0.000034675522,0.00020235758,0.0000010611253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023407862,0.00030116105,0.967466,0.00032122593,0.0003589831,0.0000043774294,0.00014774161,0.000030156485,0.0000031596178,0.000012763944,0.0075987023,0.021414936],"study_design_scores_gemma":[0.0073553384,0.0023618392,0.9475659,0.00017727943,0.00025732597,2.3129972e-7,0.000032498334,0.00014726778,0.00008990132,0.0000138240475,0.041910164,0.00008843028],"about_ca_topic_score_codex":0.22354019,"about_ca_topic_score_gemma":0.018153667,"teacher_disagreement_score":0.20538652,"about_ca_system_score_codex":0.000022898988,"about_ca_system_score_gemma":0.00012196983,"threshold_uncertainty_score":0.9997625},"labels":[],"label_agreement":null},{"id":"W2129219826","doi":"10.2147/vhrm.s30089","title":"Smoking status and sex as indicators of differences in 2582 obese patients presenting for weight management","year":2012,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Weight management; Obesity; Body mass index; Demography; Environmental health; Gerontology; Overweight; Internal medicine","score_opus":0.015337176029461825,"score_gpt":0.2900881682569985,"score_spread":0.2747509922275367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129219826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938166,0.0039859,0.00014122043,0.000023852803,0.00012975372,0.0013295168,0.00000474627,0.00001570186,0.0005527028],"genre_scores_gemma":[0.9630639,0.03615417,0.0004432763,0.00008322635,0.000030143246,0.00009702683,0.00004010083,0.00001253838,0.00007563244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867266,0.00006424998,0.00031164056,0.00022165048,0.00032506173,0.00040472826],"domain_scores_gemma":[0.9993869,0.00002926706,0.00017309695,0.00016747366,0.000014500442,0.00022872943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005799409,0.00012090113,0.00025086533,0.0003467283,0.00011924081,0.00001314728,0.000038899325,0.000044668377,0.000007546367],"category_scores_gemma":[0.000015888154,0.00009793693,0.00004439599,0.00017793686,0.000031718733,0.00007623203,0.00008310223,0.00008812833,2.2810609e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020066884,0.0002099958,0.8114901,0.0015330577,0.00011485292,9.113728e-7,0.0013250449,2.9229727e-7,4.452674e-8,0.00051177066,0.000030749954,0.18476312],"study_design_scores_gemma":[0.002777191,0.00016057109,0.9892005,0.0002206592,0.00023461437,3.272944e-7,0.0017046866,0.000019958472,0.000012292146,0.00016177923,0.005417892,0.000089582965],"about_ca_topic_score_codex":0.0002857735,"about_ca_topic_score_gemma":0.000009262164,"teacher_disagreement_score":0.18467353,"about_ca_system_score_codex":0.00006416545,"about_ca_system_score_gemma":0.000014492826,"threshold_uncertainty_score":0.3993752},"labels":[],"label_agreement":null},{"id":"W2148343657","doi":"10.2147/vhrm.s6611","title":"Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia","year":2010,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Amiodarone; Medicine; Ventricular tachycardia; Ventricular fibrillation; Cardiology; Internal medicine; Refractory (planetary science); Implantable cardioverter-defibrillator; Atrial fibrillation; Anesthesia","score_opus":0.015913797147777728,"score_gpt":0.31253658034412424,"score_spread":0.2966227831963465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148343657","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001986015,0.9923823,0.00065250706,0.000054252927,0.0001337573,0.004731563,0.00002999407,0.000014103785,0.000015490665],"genre_scores_gemma":[0.000052760028,0.9984733,0.00065801747,0.000025954087,0.00025331756,0.000199665,0.0002153301,0.000023773602,0.00009788515],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99862015,0.00018698539,0.0004092882,0.00039508348,0.00013079587,0.00025771657],"domain_scores_gemma":[0.99897987,0.00012649594,0.00035962873,0.00035184753,0.000029748604,0.00015239835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005001743,0.00027085704,0.0012306663,0.00014346697,0.00026198797,0.000013608829,0.000028959183,0.0001746001,0.0000017875986],"category_scores_gemma":[0.000020706682,0.00015857005,0.00055202,0.00014066958,0.00007932869,0.000021137017,0.000041923653,0.00017550142,9.938258e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028759658,0.000031078594,0.00006471174,0.012047288,0.0016501582,0.000029989622,0.00003302856,0.0000044449293,2.2785665e-8,0.0002426355,0.00007020162,0.9857977],"study_design_scores_gemma":[0.0011390677,0.0008960805,0.00052530406,0.0014400359,0.0065240557,0.00020607545,0.000025548967,0.000050641815,4.8137593e-7,0.000135624,0.9889301,0.00012698745],"about_ca_topic_score_codex":0.00004702699,"about_ca_topic_score_gemma":0.0000034770735,"teacher_disagreement_score":0.9888599,"about_ca_system_score_codex":0.000064716034,"about_ca_system_score_gemma":0.000088881476,"threshold_uncertainty_score":0.64662987},"labels":[],"label_agreement":null},{"id":"W2407975306","doi":"10.2147/vhrm.s100293","title":"The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery - subgroup analyses from 17,701 patients in the XAMOS study","year":2016,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Rivaroxaban; Orthopedic surgery; Anesthesia; Perioperative; Incidence (geometry); Concomitant; Antithrombotic; Surgery; Warfarin; Internal medicine; Atrial fibrillation","score_opus":0.10934566256060278,"score_gpt":0.40241725752263047,"score_spread":0.29307159496202767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407975306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957783,0.0018372835,0.00029086982,0.0001519505,0.000054526932,0.0018760097,0.0000019364015,0.0000036171086,0.000005483233],"genre_scores_gemma":[0.9883679,0.010411054,0.0010977768,0.000057314457,0.000015521056,0.000008833667,0.000004509808,0.000009239284,0.000027817614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974792,0.0009900561,0.0007797384,0.00020083715,0.00039530752,0.00015485084],"domain_scores_gemma":[0.99703306,0.002062231,0.00044789494,0.00036050694,0.000045346365,0.000050932915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00250193,0.000121117,0.0006313919,0.00026804293,0.000042123043,0.000005267622,0.00007195988,0.00003792734,0.0000027895612],"category_scores_gemma":[0.0006120014,0.000055393608,0.00010930003,0.00037773547,0.000055210472,0.000043595308,0.00006774269,0.00006840367,1.9987793e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041088622,0.00014092225,0.90682465,0.00070022175,0.00024430171,0.000007400269,0.00032459767,0.0000039342794,0.000010791234,0.00010227207,0.0000241792,0.091205865],"study_design_scores_gemma":[0.0024504696,0.0011139463,0.9946611,0.00028789608,0.00028833738,1.6377427e-7,0.0004865084,0.000047848298,0.000059413447,0.00006503775,0.00048421934,0.000055044926],"about_ca_topic_score_codex":0.0016524441,"about_ca_topic_score_gemma":0.0001327047,"teacher_disagreement_score":0.09115082,"about_ca_system_score_codex":0.000019150286,"about_ca_system_score_gemma":0.000019691453,"threshold_uncertainty_score":0.24980122},"labels":[],"label_agreement":null},{"id":"W2581401145","doi":"10.2147/vhrm.s123631","title":"Length of stay, hospitalization cost, and in-hospital mortality in US adult inpatients with immune thrombocytopenic purpura, 2006–2012","year":2017,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Amgen; Amgen Foundation","keywords":"Medicine; Confidence interval; Thrombocytopenic purpura; Thrombotic thrombocytopenic purpura; Population; Pediatrics; Healthcare Cost and Utilization Project; Emergency medicine; Internal medicine; Demography; Health care; Environmental health","score_opus":0.011442180233140059,"score_gpt":0.28256826643944055,"score_spread":0.2711260862063005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581401145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98967284,0.007460192,0.00009315392,0.00015482298,0.00006377694,0.0020797346,0.000024176927,0.0000101872665,0.00044110545],"genre_scores_gemma":[0.9161537,0.08310138,0.00043116094,0.000071092414,0.000006444296,0.00006559589,0.000096844095,0.000015454456,0.000058295023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986223,0.000056610035,0.00038075325,0.0003363955,0.00028085642,0.00032306113],"domain_scores_gemma":[0.99896663,0.00000691907,0.00031067614,0.00050495187,0.00004662289,0.0001642149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028456224,0.00018110253,0.00051451864,0.0001422978,0.00017530282,0.00002980861,0.000079312646,0.000055821503,0.000007509304],"category_scores_gemma":[0.00002364305,0.00013800604,0.00004174467,0.00010298242,0.00009711645,0.00021541778,0.000101194266,0.000116673,0.0000023642674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013885205,0.0007469039,0.9666887,0.00050484616,0.0003124979,0.00005878611,0.00047109756,0.000012894174,2.2459052e-7,0.000115295494,0.000035695073,0.030914217],"study_design_scores_gemma":[0.007971151,0.0007097074,0.9883719,0.00034163124,0.00013568415,0.0000027360554,0.0002652819,0.00012677675,0.000004748753,0.00011816421,0.0018187308,0.00013350714],"about_ca_topic_score_codex":0.008761545,"about_ca_topic_score_gemma":0.004887732,"teacher_disagreement_score":0.075641185,"about_ca_system_score_codex":0.00008387163,"about_ca_system_score_gemma":0.00004615316,"threshold_uncertainty_score":0.9978392},"labels":[],"label_agreement":null},{"id":"W2589727170","doi":"10.2147/vhrm.s121086","title":"Prevalence of mild cognitive impairment in employable patients after acute coronary event in cardiac rehabilitation","year":2017,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Cardiac Health and Mental Health","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Universität Potsdam; Deutsche Forschungsgemeinschaft","keywords":"Medicine; Montreal Cognitive Assessment; Rehabilitation; Internal medicine; Coronary artery disease; Observational study; Prospective cohort study; Cognitive impairment; Cognition; Physical therapy; Cardiology; Disease","score_opus":0.007507652049323215,"score_gpt":0.30594291365464243,"score_spread":0.29843526160531925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589727170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867206,0.0079127615,0.00001561654,0.0002981989,0.00023217434,0.0044980855,0.00009908315,0.000009793443,0.0002136484],"genre_scores_gemma":[0.90168107,0.09664775,0.00064218446,0.00046488282,0.000019574469,0.0004142082,0.00003944513,0.000014323964,0.00007656165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784684,0.00026218052,0.0006092166,0.0004055229,0.00039246163,0.00048377877],"domain_scores_gemma":[0.99877065,0.000053197895,0.0002651574,0.00043915588,0.00005410854,0.0004177366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014326719,0.00016009659,0.0004996869,0.00022826041,0.00015305296,0.000008198406,0.00006055846,0.00005989098,0.000010351768],"category_scores_gemma":[0.00004666064,0.00014400865,0.00013859579,0.00009486132,0.00007471588,0.0001037242,0.00012028123,0.0001846612,0.0000059398435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011341192,0.0005737656,0.939382,0.008575915,0.00006823801,0.000013916699,0.0012254501,0.000002446451,6.154738e-8,0.000012020595,0.0001128792,0.04889919],"study_design_scores_gemma":[0.0058111027,0.0018637831,0.9884248,0.001961399,0.0001335678,6.2699075e-7,0.00059631554,0.000029884439,0.000003281992,0.000050396404,0.0010199388,0.00010491743],"about_ca_topic_score_codex":0.0030517469,"about_ca_topic_score_gemma":0.00018290202,"teacher_disagreement_score":0.088734984,"about_ca_system_score_codex":0.00040637102,"about_ca_system_score_gemma":0.00017684398,"threshold_uncertainty_score":0.58725023},"labels":[],"label_agreement":null},{"id":"W2626741611","doi":"10.2147/vhrm.s138800","title":"Worksite-based cardiovascular risk screening and management: a feasibility study","year":2017,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Workplace Health and Well-being","field":"Health Professions","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Calgary; Alberta Health; Libin Cardiovascular Institute of Alberta; Women and Children’s Health Research Institute; University of Alberta","funders":"","keywords":"Medicine; Framingham Risk Score; Dyslipidemia; Risk factor; Blood pressure; Diabetes mellitus; Internal medicine; Physical therapy; Emergency medicine; Disease; Endocrinology","score_opus":0.037189137697289106,"score_gpt":0.3622636777385877,"score_spread":0.3250745400412986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626741611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81817114,0.08139773,0.05123024,0.0017256506,0.0016350866,0.028307142,0.000060385417,0.00061539945,0.016857252],"genre_scores_gemma":[0.69069636,0.28340048,0.02015501,0.0026343372,0.0004956969,0.0013638788,0.000044603974,0.00014421056,0.001065446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99275,0.0026317358,0.0009819592,0.0013174808,0.0008096546,0.0015091548],"domain_scores_gemma":[0.99499714,0.00021703879,0.00083598687,0.0027149133,0.00008350229,0.0011513985],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.010196516,0.0004749314,0.0009442661,0.00031897135,0.011903411,0.00016068578,0.00045682298,0.00018947705,0.000038748854],"category_scores_gemma":[0.0001668336,0.00041699046,0.00030686386,0.0002286283,0.00015411469,0.00022638561,0.0008475022,0.0011417312,0.00006714951],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018760281,0.00018870312,0.7221855,0.0030218523,0.0009935701,0.000050616924,0.0012804817,0.000107815795,4.265165e-9,0.0004118645,0.00067417993,0.27089784],"study_design_scores_gemma":[0.0094807,0.00030420593,0.79770404,0.00084715843,0.00088659616,7.025379e-7,0.006066068,0.001396286,8.212928e-8,0.0004583322,0.18242234,0.00043350123],"about_ca_topic_score_codex":0.0067962855,"about_ca_topic_score_gemma":0.000874712,"teacher_disagreement_score":0.27046433,"about_ca_system_score_codex":0.00019834643,"about_ca_system_score_gemma":0.00011627137,"threshold_uncertainty_score":0.9998282},"labels":[],"label_agreement":null},{"id":"W2744179443","doi":"10.2147/vhrm.s108874","title":"Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance","year":2017,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; University of Toronto; University Health Network","funders":"Princess Margaret Hospital Foundation","keywords":"Medicine; Myeloid leukemia; Tyrosine kinase; Tyrosine-kinase inhibitor; Immunology; Internal medicine; Cancer; Receptor","score_opus":0.02911039164264766,"score_gpt":0.30605158630237966,"score_spread":0.276941194659732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744179443","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011227077,0.9920658,0.00010809535,0.000009723375,0.00026784602,0.0056197313,0.00009984337,0.00006074222,0.00064549904],"genre_scores_gemma":[0.00079422945,0.9973278,0.00044021467,0.000014861534,0.0002930345,0.00050662505,0.00026612045,0.00012967776,0.00022741198],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99394405,0.00097267923,0.0015090766,0.0015252485,0.001063904,0.0009850506],"domain_scores_gemma":[0.9958651,0.00009906368,0.0008527348,0.0025892348,0.00009370404,0.0005001563],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028947683,0.0010461262,0.0060780435,0.0007349105,0.00034804686,0.00012338636,0.00031936044,0.00046973594,0.000010787683],"category_scores_gemma":[0.00008577898,0.00085542974,0.002387756,0.00040603036,0.0004115652,0.00023556597,0.0004959842,0.000844361,0.000008589593],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025926693,0.000074105184,0.00024863335,0.10279886,0.013248365,0.00027454906,0.00018881445,0.00012788898,2.8119864e-8,0.000106400825,0.00011254369,0.8827939],"study_design_scores_gemma":[0.0052185673,0.00050354155,0.001013457,0.026524192,0.005097064,0.000085528234,0.0005943705,0.00003809457,0.0000013526778,0.00004371743,0.9602509,0.0006292208],"about_ca_topic_score_codex":0.0064482754,"about_ca_topic_score_gemma":0.0004330031,"teacher_disagreement_score":0.9601383,"about_ca_system_score_codex":0.003668841,"about_ca_system_score_gemma":0.0037431042,"threshold_uncertainty_score":0.99938965},"labels":[],"label_agreement":null},{"id":"W2799355091","doi":"10.2147/vhrm.s150474","title":"Incidence of symptomatic venous thromboembolism in 2372 knee and hip replacement patients after discharge: data from a thromboprophylaxis registry in Montreal, Canada","year":2018,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Dabigatran; Pulmonary embolism; Arthroplasty; Incidence (geometry); Knee replacement; Venous thrombosis; Hip replacement; Apixaban; Anticoagulant; Surgery; Anesthesia; Fondaparinux; Thrombosis; Venous thromboembolism; Rivaroxaban; Warfarin; Internal medicine; Atrial fibrillation","score_opus":0.009369681575976825,"score_gpt":0.25063240969650424,"score_spread":0.24126272812052743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799355091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98619026,0.010707512,0.00004228246,0.00024749475,0.0002014513,0.0021604819,0.0001199737,0.000016159871,0.00031441115],"genre_scores_gemma":[0.962348,0.035541113,0.0008010573,0.00087231817,0.00006157163,0.00013819446,0.00018037748,0.000027838496,0.00002954058],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99700487,0.0001542599,0.0008000431,0.0008664298,0.00062636705,0.00054804824],"domain_scores_gemma":[0.99783313,0.000044935317,0.00032052756,0.0014354237,0.000052494823,0.00031349147],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00071042846,0.00029161727,0.0009901575,0.00023005539,0.00011329514,0.00002805505,0.00023395532,0.000070719594,0.00005692771],"category_scores_gemma":[0.00007224509,0.00025028776,0.0000391082,0.00030525334,0.00012913575,0.00013875074,0.0006626907,0.00019712733,0.0000054260645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002259433,0.0015361827,0.9255885,0.0025543044,0.0005230359,0.00006846477,0.0023539804,0.0000062179606,6.993583e-7,0.00006842625,0.0040424997,0.06303175],"study_design_scores_gemma":[0.0030636126,0.00087412965,0.9887129,0.0010945906,0.00020892774,9.314262e-7,0.00095924945,0.0007385534,0.0000035154205,0.00030822292,0.0038181366,0.00021720113],"about_ca_topic_score_codex":0.75910693,"about_ca_topic_score_gemma":0.6823717,"teacher_disagreement_score":0.07673522,"about_ca_system_score_codex":0.00027934447,"about_ca_system_score_gemma":0.0002153948,"threshold_uncertainty_score":0.99999493},"labels":[],"label_agreement":null},{"id":"W2888588674","doi":"10.2147/vhrm.s166111","title":"Prevalence of cardiovascular disease among Bangladeshi adult population: a systematic review and meta-analysis of the studies","year":2018,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Meta-analysis; Epidemiology; Disease; Population; MEDLINE; Demography; Systematic review; Subgroup analysis; Prevalence; Environmental health; Gerontology; Pathology","score_opus":0.055743270723846015,"score_gpt":0.3281741889417558,"score_spread":0.2724309182179098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888588674","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000039448398,0.98761064,0.00005385553,0.000033911736,0.00006167464,0.011963151,0.00019287202,0.000022652854,0.000021791604],"genre_scores_gemma":[0.00006514429,0.9979188,0.00021355781,0.0001783071,0.000041191088,0.0012551144,0.000060176062,0.000046637055,0.00022107024],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9933106,0.0021674607,0.0019522078,0.0008818535,0.0013272918,0.00036062233],"domain_scores_gemma":[0.9944851,0.00010315902,0.0015962844,0.003094166,0.00033570954,0.0003855867],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0043845996,0.00061214884,0.013327303,0.00045844849,0.00020145527,0.000018042756,0.0003027158,0.000117784424,0.000014331457],"category_scores_gemma":[0.0005304034,0.00031899405,0.012053883,0.0012917628,0.00030119083,0.0000618489,0.0003397035,0.0002479104,0.0000018853349],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000015561073,0.000028746052,0.00007291294,0.5531073,0.4217129,0.0000030607628,0.00004977169,0.0000050323056,8.804515e-12,0.000028674622,0.00004134495,0.024948683],"study_design_scores_gemma":[0.00022821905,0.000059868264,0.00117599,0.11637923,0.843558,0.000003095903,0.00006210224,0.000011269537,8.20816e-9,0.000011718291,0.03829697,0.0002135076],"about_ca_topic_score_codex":0.002418188,"about_ca_topic_score_gemma":0.0000736278,"teacher_disagreement_score":0.43672806,"about_ca_system_score_codex":0.00009267476,"about_ca_system_score_gemma":0.00010237772,"threshold_uncertainty_score":0.9999262},"labels":[],"label_agreement":null},{"id":"W2892141990","doi":"10.2147/vhrm.s170141","title":"Antihypertensive effect of the mineralocorticoid receptor antagonist eplerenone: a pooled analysis of patient-level data from comparative trials using regulatory-approved doses","year":2018,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Pfizer (Canada)","funders":"Pfizer","keywords":"Eplerenone; Medicine; Mineralocorticoid receptor; Spironolactone; Aldosterone; Pharmacology; Mineralocorticoid; Antagonist; Internal medicine; Endocrinology; Receptor","score_opus":0.10101055363350885,"score_gpt":0.35716111717230936,"score_spread":0.2561505635388005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892141990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99110836,0.006164307,0.00052504294,0.00016817175,0.00017107186,0.0014887573,0.00032288933,0.000011542247,0.00003986522],"genre_scores_gemma":[0.9923503,0.0034904736,0.003235789,0.00036261437,0.0000920735,0.0000075865782,0.000419106,0.000013589536,0.000028503151],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971648,0.00082315755,0.0008585009,0.00043065246,0.00051483134,0.00020806788],"domain_scores_gemma":[0.997523,0.00020259111,0.0008258555,0.0010371228,0.0002324726,0.00017896394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012163601,0.00019589861,0.0015119085,0.00025060368,0.00021684096,0.000013092514,0.00014582365,0.00006225866,0.000041340754],"category_scores_gemma":[0.00027766355,0.00010936617,0.00028185186,0.0006663019,0.0002256085,0.000053289015,0.00021237126,0.00009112519,0.000002068679],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017867155,0.002423336,0.36962292,0.0029551703,0.12334052,0.00003613856,0.009721721,0.00064114033,0.05511486,0.0006805015,0.023099856,0.39449668],"study_design_scores_gemma":[0.015047055,0.0027401804,0.73628634,0.00098808,0.045471955,0.0000066544712,0.0027485092,0.14773227,0.011217307,0.000037598842,0.037240505,0.00048352696],"about_ca_topic_score_codex":0.002835007,"about_ca_topic_score_gemma":0.00018819132,"teacher_disagreement_score":0.39401317,"about_ca_system_score_codex":0.0000455915,"about_ca_system_score_gemma":0.00010106766,"threshold_uncertainty_score":0.4459823},"labels":[],"label_agreement":null},{"id":"W2964134386","doi":"10.2147/vhrm.s206747","title":"<p>Prognostic implications of left ventricular strain by speckle-tracking echocardiography in the general population: a meta-analysis</p>","year":2019,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Imam Abdulrahman Bin Faisal University; University College London; British Heart Foundation; Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Speckle tracking echocardiography; Internal medicine; Cardiology; Meta-analysis; Population; Clinical endpoint; Heart failure; Ejection fraction; Randomized controlled trial","score_opus":0.04906744595791978,"score_gpt":0.3275778628829054,"score_spread":0.2785104169249856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964134386","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026228366,0.99156773,0.0025446732,0.00011782784,0.00015889895,0.0047768485,0.0003423428,0.000044121058,0.00018526922],"genre_scores_gemma":[0.00073532533,0.99516654,0.0005032894,0.00024862282,0.00012434418,0.0002481723,0.0027742821,0.000058700807,0.00014073259],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99440414,0.0013700819,0.0015575044,0.0009935953,0.0010897211,0.00058493594],"domain_scores_gemma":[0.996796,0.00015146831,0.0008753119,0.0017664507,0.00009550354,0.00031526238],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030702797,0.0006460663,0.0046998304,0.0015775595,0.00025148343,0.00007799555,0.00031311778,0.00027553024,0.00007240695],"category_scores_gemma":[0.000047641242,0.00039458318,0.009288432,0.0026356895,0.00006953028,0.00006525276,0.000103106824,0.0005556506,0.000015134217],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014619974,0.00046483634,0.023680674,0.023813874,0.39520723,0.00006491393,0.00021199672,0.0005923222,7.214664e-8,0.0016990572,0.0030971554,0.55115324],"study_design_scores_gemma":[0.0004560522,0.00007345619,0.027111338,0.000286299,0.28475678,0.000032911936,0.00005013428,0.00002661366,1.6105416e-8,0.00002358939,0.6869298,0.00025295958],"about_ca_topic_score_codex":0.00030792048,"about_ca_topic_score_gemma":0.00009422521,"teacher_disagreement_score":0.6838327,"about_ca_system_score_codex":0.00016932793,"about_ca_system_score_gemma":0.00013605597,"threshold_uncertainty_score":0.99985063},"labels":[],"label_agreement":null},{"id":"W2971102449","doi":"10.2147/vhrm.s209003","title":"<p>PROspective evaluation of coronary FLOW reserve and molecular biomarkers in patients with established coronary artery disease the PROFLOW-trial: cross-sectional evaluation of coronary flow reserve</p>","year":2019,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Coronary Interventions and Diagnostics","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Coronary flow reserve; Cardiology; Internal medicine; Mace; Coronary artery disease; Myocardial infarction; Fractional flow reserve; Angioplasty; Prospective cohort study; Angina; Canadian Cardiovascular Society; Percutaneous coronary intervention; Coronary angiography","score_opus":0.019195714221841825,"score_gpt":0.3031631327025165,"score_spread":0.28396741848067464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971102449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749886,0.014121352,0.00013260514,0.00014691877,0.00032718552,0.009842224,0.00016631994,0.000021480908,0.00025335865],"genre_scores_gemma":[0.9947475,0.0029951967,0.00069295394,0.0000916762,0.00003339449,0.0005355283,0.00082094705,0.000038346374,0.000044466484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944999,0.0010718405,0.0009376212,0.0007232816,0.0023813096,0.00038605378],"domain_scores_gemma":[0.99709445,0.0001718557,0.0005014381,0.0008385079,0.0011026837,0.0002910814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055752755,0.00030380732,0.0004977829,0.0003906909,0.00020228594,0.00004157423,0.00015543596,0.00010372962,0.00015719938],"category_scores_gemma":[0.0004130818,0.00022784248,0.0001910197,0.0004887874,0.00021872882,0.00027339227,0.00020420586,0.00021248791,0.000003906563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021050561,0.0014888438,0.93966526,0.001012476,0.0010280234,0.000018717517,0.00020231733,0.0048823366,0.0000045192264,0.00019227636,0.00022541829,0.030229239],"study_design_scores_gemma":[0.050664183,0.0028288942,0.88293517,0.0006008346,0.00094675506,0.0000051358224,0.0001791088,0.060743235,0.0000034282857,0.00071745954,0.00018330093,0.00019249058],"about_ca_topic_score_codex":0.00020430928,"about_ca_topic_score_gemma":0.00031110214,"teacher_disagreement_score":0.056730095,"about_ca_system_score_codex":0.0004412383,"about_ca_system_score_gemma":0.0005594895,"threshold_uncertainty_score":0.92911464},"labels":[],"label_agreement":null},{"id":"W2982946589","doi":"10.2147/vhrm.s204097","title":"<p>Periodontitis As A Risk Factor For Stroke: A Systematic Review And Meta-Analysis</p>","year":2019,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Oral microbiology and periodontitis research","field":"Dentistry","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Periodontitis; Meta-analysis; Stroke (engine); Odds ratio; Critical appraisal; Risk factor; Cohort study; Systematic review; Cohort; Internal medicine; Case-control study; MEDLINE; Pathology; Alternative medicine","score_opus":0.06491950110310094,"score_gpt":0.3692482673531636,"score_spread":0.30432876625006267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982946589","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011241307,0.9749707,0.00050171424,0.000048606984,0.0002328355,0.016174186,0.007806851,0.00006413772,0.00018975193],"genre_scores_gemma":[0.0000037320494,0.9799702,0.0006744932,0.00040270961,0.00005240475,0.002416212,0.0006447982,0.00009754615,0.015737861],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99141556,0.0032276313,0.002114881,0.0016297256,0.0005540133,0.0010581684],"domain_scores_gemma":[0.9953103,0.0003770121,0.0017325334,0.0018356927,0.00015233393,0.0005921169],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0036358063,0.0010254115,0.012079856,0.0007724173,0.0007095804,0.00033919563,0.00068183267,0.0005135848,0.000973574],"category_scores_gemma":[0.00028610107,0.0006868117,0.0051397607,0.0007540429,0.00013676428,0.00013211598,0.0005212433,0.0007148736,0.00061146764],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000066229577,0.000045030745,0.000017133843,0.7471231,0.20723435,0.000027613598,0.000034353045,3.7352567e-7,9.9296e-9,0.00028618303,0.0015256818,0.043699536],"study_design_scores_gemma":[0.00031084285,0.00013922183,0.000017691362,0.00911787,0.41745535,0.00003461481,0.000011183368,0.0000046861633,1.0763102e-8,0.000010212311,0.57251614,0.000382202],"about_ca_topic_score_codex":0.00034022442,"about_ca_topic_score_gemma":0.0011649427,"teacher_disagreement_score":0.7380052,"about_ca_system_score_codex":0.00017439992,"about_ca_system_score_gemma":0.00024387802,"threshold_uncertainty_score":0.9999397},"labels":[],"label_agreement":null},{"id":"W3087646696","doi":"10.2147/vhrm.s270751","title":"<p>Effect of Switching from Low-Dose Simvastatin to High-Dose Atorvastatin on Glucose Homeostasis and Cognitive Function in Type 2 Diabetes</p>","year":2020,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Faculty of Medicine Siriraj Hospital, Mahidol University; Mahidol University; Pfizer","keywords":"Medicine; Atorvastatin; Internal medicine; Glycated hemoglobin; Simvastatin; Type 2 diabetes; Glycemic; Endocrinology; Insulin resistance; Statin; Insulin; Glucose homeostasis; Diabetes mellitus","score_opus":0.008321686799131152,"score_gpt":0.24242821768342257,"score_spread":0.23410653088429142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087646696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97343254,0.022429945,0.00039180345,0.00059047755,0.00015645876,0.0027107578,0.000053268464,0.00006385931,0.00017089938],"genre_scores_gemma":[0.9678966,0.027971366,0.0009487126,0.0026522817,0.000073358075,0.00013612332,0.0002468628,0.000046988996,0.000027748027],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997573,0.00029520082,0.0004887721,0.0006936146,0.00045214235,0.00049724395],"domain_scores_gemma":[0.99866354,0.00022460482,0.00020630517,0.00027318476,0.000045160483,0.0005872117],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006575834,0.00035525297,0.0007614078,0.00033344873,0.00012161254,0.00003787764,0.000066226276,0.000058929352,0.00003444278],"category_scores_gemma":[0.0001392945,0.00029126325,0.00009784803,0.00054368784,0.000032109598,0.000086996544,0.00017309228,0.00017189712,0.000047722235],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023335032,0.00038732428,0.020281661,0.0021030363,0.0014286782,0.000056356737,0.0013253235,0.00008150453,0.000116559684,0.00023636533,0.0009049467,0.9707447],"study_design_scores_gemma":[0.048620928,0.033894744,0.83964676,0.0044411705,0.0054663382,5.384555e-7,0.00178813,0.0043047327,0.0016688934,0.00041616143,0.05852911,0.0012224762],"about_ca_topic_score_codex":0.00021540171,"about_ca_topic_score_gemma":0.00008525227,"teacher_disagreement_score":0.96952224,"about_ca_system_score_codex":0.00008779565,"about_ca_system_score_gemma":0.000034458324,"threshold_uncertainty_score":0.9999539},"labels":[],"label_agreement":null},{"id":"W3097672180","doi":"10.2147/vhrm.s276477","title":"<p>Risk of Atrial Fibrillation, Ischemic Stroke and Cognitive Impairment: Study of a Population Cohort ≥65 Years of Age</p>","year":2020,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Sociedad Española de Medicina de Familia y Comunitaria","keywords":"Medicine; Atrial fibrillation; Stroke (engine); Internal medicine; Incidence (geometry); Cohort; Population; Retrospective cohort study; Cohort study; Observational study; Montreal Cognitive Assessment; Cardiology; Pediatrics; Physical therapy; Cognitive impairment; Disease","score_opus":0.02045007389387467,"score_gpt":0.2928727124069839,"score_spread":0.27242263851310927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097672180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894606,0.006553433,0.0003454718,0.000103435406,0.00007350439,0.0031194657,0.000044262877,0.000028376477,0.00027145358],"genre_scores_gemma":[0.9773297,0.02152568,0.00064149074,0.0000430379,0.00021941289,0.0000035687885,0.00011150943,0.000019422005,0.00010622358],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978504,0.00021004357,0.0008210696,0.00035915134,0.00056208536,0.0001972368],"domain_scores_gemma":[0.9986527,0.000102089354,0.00073077955,0.0002181245,0.00008961552,0.00020670694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075950683,0.00017304491,0.0007227857,0.0002249406,0.000087154425,0.000010143687,0.000048023212,0.00005831609,0.000021297437],"category_scores_gemma":[0.00015818625,0.00015981925,0.000211493,0.00033031096,0.000053945736,0.00007464927,0.00013043874,0.00008075434,0.0000019528773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008792796,0.000033922086,0.9388827,0.0011363897,0.0019607213,0.0000046432533,0.0017945236,0.00035291974,0.000014252222,0.00011847264,0.00027062555,0.05455152],"study_design_scores_gemma":[0.008700457,0.0017575099,0.9730219,0.00013452425,0.0022857606,6.2841707e-7,0.0013471849,0.0012624438,0.000010419425,0.000025477779,0.011320243,0.00013341982],"about_ca_topic_score_codex":0.0004169089,"about_ca_topic_score_gemma":0.00004215873,"teacher_disagreement_score":0.054418102,"about_ca_system_score_codex":0.000026594718,"about_ca_system_score_gemma":0.000028107877,"threshold_uncertainty_score":0.651724},"labels":[],"label_agreement":null},{"id":"W3198724880","doi":"10.2147/vhrm.s315248","title":"The Relationship Between Body Mass Index and In-Hospital Mortality in the Contemporary Era of an Acute Myocardial Infarction Management","year":2021,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Body mass index; Myocardial infarction; Logistic regression; Obesity; Internal medicine; Obesity paradox; Overweight","score_opus":0.019661668367810786,"score_gpt":0.2890876318159248,"score_spread":0.269425963448114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198724880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98876333,0.00726827,0.00057923986,0.0011474134,0.00021158281,0.0013310632,0.0000098469545,0.00001773948,0.00067153125],"genre_scores_gemma":[0.95387757,0.045453068,0.00013918626,0.0002671586,0.00006652672,0.000056186247,0.00008938651,0.000011327773,0.000039619845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978982,0.0005987085,0.00045675688,0.00033212456,0.00048295534,0.00023121962],"domain_scores_gemma":[0.999055,0.00009840789,0.00012373236,0.0005482591,0.00003259835,0.0001419755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020326583,0.00014421128,0.00034117696,0.00012921351,0.00024467535,0.00004142014,0.000069319234,0.000069987866,0.0000018559726],"category_scores_gemma":[0.000034614888,0.00009171505,0.00016439456,0.000408467,0.000084508916,0.000093994735,0.0000744763,0.00040612475,0.0000011393862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007010972,0.000093579416,0.97336173,0.00021552567,0.0009639157,0.00006440344,0.00045138117,0.00002794962,1.04802545e-7,0.0008089792,0.00012218393,0.02382015],"study_design_scores_gemma":[0.0024970202,0.00016565838,0.972683,0.000078076955,0.00032141138,0.000005675335,0.0040879603,0.000112155954,7.9688715e-7,0.00051581836,0.01944094,0.00009148849],"about_ca_topic_score_codex":0.0008703581,"about_ca_topic_score_gemma":0.00017212747,"teacher_disagreement_score":0.0381848,"about_ca_system_score_codex":0.00006879227,"about_ca_system_score_gemma":0.00007058697,"threshold_uncertainty_score":0.3740031},"labels":[],"label_agreement":null},{"id":"W3208260249","doi":"10.2147/vhrm.s333542","title":"Updating the VIVOPTIM Program for the Assessment of Cardiovascular Risk","year":2021,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Health Promotion and Cardiovascular Prevention","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Mutuelle Générale de l'Education Nationale","keywords":"Medicine; Risk assessment; Internal medicine","score_opus":0.017898067748323997,"score_gpt":0.3396835670574516,"score_spread":0.32178549930912764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208260249","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018123202,0.2244575,0.7399075,0.003122789,0.00057885505,0.011484137,0.000032690208,0.00013747235,0.0021558302],"genre_scores_gemma":[0.096348725,0.82007605,0.079162225,0.0013313337,0.00040009906,0.0020960362,0.00014700316,0.00006550426,0.000373],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99657005,0.0014735389,0.00052999944,0.00039343158,0.00064523023,0.00038777842],"domain_scores_gemma":[0.99822897,0.00010993496,0.0002437517,0.0010200737,0.00018881165,0.00020844133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010170604,0.00016135443,0.0004947579,0.000056693923,0.0007779653,0.000036011857,0.0001051891,0.000060103645,0.000020324484],"category_scores_gemma":[0.000116356714,0.00009258287,0.0010431772,0.00031113534,0.00007101788,0.000035913523,0.00011427882,0.0003021199,0.0000023381],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000066274956,0.0001851019,0.0023845183,0.0019407242,0.0050627138,0.000005200628,0.00018649873,0.00080934394,2.2931981e-7,0.0013452886,0.00043427275,0.9876395],"study_design_scores_gemma":[0.003096677,0.00038428252,0.067696646,0.00022170672,0.0031679773,0.000022740755,0.0026911583,0.009758619,0.000010877651,0.0001993221,0.91262585,0.00012411404],"about_ca_topic_score_codex":0.0002700575,"about_ca_topic_score_gemma":0.000019707652,"teacher_disagreement_score":0.9875154,"about_ca_system_score_codex":0.000076476405,"about_ca_system_score_gemma":0.00024435663,"threshold_uncertainty_score":0.5983559},"labels":[],"label_agreement":null},{"id":"W3211546413","doi":"10.2147/vhrm.s334982","title":"An Association Between C-Reactive Protein Levels and the Occurrence of Cognitive Dysfunction After Heart Valve Replacement","year":2021,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Intensive Care Unit Cognitive Disorders","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Interquartile range; Postoperative cognitive dysfunction; Montreal Cognitive Assessment; C-reactive protein; Internal medicine; Proinflammatory cytokine; Cardiology; Systemic inflammation; Cognition; Valve replacement; Anesthesia; Inflammation; Dementia; Stenosis; Disease; Psychiatry","score_opus":0.012399568803335132,"score_gpt":0.2830306335509584,"score_spread":0.2706310647476233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211546413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855025,0.0055509806,0.0041783764,0.0015931394,0.000078668556,0.0025176015,0.00013543492,0.000019570265,0.00042376135],"genre_scores_gemma":[0.9915926,0.0020883486,0.00030184945,0.0054699103,0.00004372498,0.00020229614,0.0001903004,0.000011105103,0.00009989032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821544,0.0005562574,0.00027986747,0.00034764933,0.0003720203,0.00022878667],"domain_scores_gemma":[0.99762243,0.00017346701,0.00022180768,0.00019290586,0.0016452256,0.00014418286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011398041,0.00013748578,0.0003474658,0.00009143413,0.0001533761,0.000019785562,0.00002231626,0.000053232186,0.000020777592],"category_scores_gemma":[0.0011844129,0.00010161473,0.00011471241,0.00017506619,0.0001011978,0.00007188397,0.00005397908,0.00021105481,0.0000037259979],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029078936,0.00046363566,0.8625922,0.0017953719,0.0054124654,0.000018371089,0.008222922,0.0000019670763,0.000025927373,0.000647985,0.0011393377,0.11677188],"study_design_scores_gemma":[0.010260575,0.0011935754,0.9466836,0.0011087552,0.0017221879,0.00000528984,0.031119144,0.00007644808,0.0005646658,0.0004297105,0.0066272155,0.00020885056],"about_ca_topic_score_codex":0.00024716894,"about_ca_topic_score_gemma":0.000031162854,"teacher_disagreement_score":0.11656303,"about_ca_system_score_codex":0.0001176878,"about_ca_system_score_gemma":0.00010257176,"threshold_uncertainty_score":0.41437283},"labels":[],"label_agreement":null},{"id":"W4247685545","doi":"10.2147/vhrm.s2347","title":"Effect of short-term lycopene supplementation and postprandial dyslipidemia on plasma antioxidants and biomarkers of endothelial health in young, healthy individuals","year":2008,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Antioxidant Activity and Oxidative Stress","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"University of Waterloo; Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation of Canada","keywords":"Medicine; Dyslipidemia; Postprandial; Lycopene; Cardiovascular health; Internal medicine; Endothelial dysfunction; Endocrinology; Obesity; Antioxidant; Disease; Insulin; Biochemistry","score_opus":0.013477567764619074,"score_gpt":0.3068498764235746,"score_spread":0.2933723086589555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247685545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932888,0.003667665,0.00012051754,0.00038947203,0.00008652214,0.0021051255,0.0001947712,0.000012816747,0.00013427009],"genre_scores_gemma":[0.8646828,0.13437183,0.0005928628,0.00018293915,0.000029365938,0.000023929146,0.000091893846,0.000015002463,0.000009384761],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975687,0.0006431355,0.00064206327,0.00041379462,0.0003530957,0.00037918033],"domain_scores_gemma":[0.99896944,0.00017415313,0.0003409365,0.00019589897,0.000021940199,0.00029761562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017885056,0.00022634746,0.00079913577,0.00044140144,0.00020416561,0.0000072874227,0.0000486859,0.000069203146,0.000008237486],"category_scores_gemma":[0.00004661289,0.00018572246,0.000068778994,0.00020985419,0.000194653,0.00010197706,0.000068943984,0.0001770953,5.9423877e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036189943,0.00024108368,0.86112875,0.0034236826,0.000325083,0.000012656372,0.0011871068,0.0000025080326,0.0000718407,0.00011771887,0.00013682408,0.12973373],"study_design_scores_gemma":[0.0121277245,0.010179857,0.974563,0.00077206554,0.000113254646,0.000031067804,0.00039469352,0.000094162104,0.0010233885,0.000012815779,0.0005340221,0.00015396372],"about_ca_topic_score_codex":0.0015901702,"about_ca_topic_score_gemma":0.00036423755,"teacher_disagreement_score":0.13070416,"about_ca_system_score_codex":0.00006787,"about_ca_system_score_gemma":0.00009504,"threshold_uncertainty_score":0.7573542},"labels":[],"label_agreement":null},{"id":"W4281694823","doi":"10.2147/vhrm.s274857","title":"Bidirectional Ventricular Tachycardia: Challenges and Solutions","year":2022,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cardiology; Internal medicine; Ventricular tachycardia; Tachycardia; Intensive care medicine","score_opus":0.039518305783862825,"score_gpt":0.30485671037866763,"score_spread":0.2653384045948048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281694823","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011444288,0.9970671,0.00002363411,0.00014101667,0.00029823367,0.0013782757,0.000026281637,0.00006044794,0.000993579],"genre_scores_gemma":[0.0000011462653,0.9984795,0.00017542673,0.00015735628,0.00031213235,0.00040496807,0.00023228006,0.000032798198,0.00020442995],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99793154,0.00047859323,0.00033477374,0.0005708258,0.00025342658,0.0004308323],"domain_scores_gemma":[0.9990818,0.0000728991,0.00018235965,0.00035195675,0.0000121079765,0.00029886691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006808644,0.00028916876,0.0013272502,0.00030180032,0.0006059427,0.000009557576,0.00004378506,0.00012921827,0.000036963327],"category_scores_gemma":[0.000021668719,0.00023163558,0.00058170065,0.00019735184,0.00006190623,0.000021354417,0.00021456415,0.0005776242,0.00001456607],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000071848203,0.000051014897,0.0000020694556,0.016600555,0.0018478194,0.00045059022,0.000034443376,0.0000016013164,3.96283e-10,0.0015306175,0.0008996535,0.97857445],"study_design_scores_gemma":[0.0004052083,0.0002245456,0.00009954095,0.0010219417,0.002502072,0.0010014737,0.000077374534,0.000004575191,2.5151217e-9,0.00012125717,0.9943606,0.00018136321],"about_ca_topic_score_codex":0.00003381155,"about_ca_topic_score_gemma":0.0000023455787,"teacher_disagreement_score":0.993461,"about_ca_system_score_codex":0.00016092423,"about_ca_system_score_gemma":0.00017424044,"threshold_uncertainty_score":0.9445825},"labels":[],"label_agreement":null},{"id":"W4304807925","doi":"10.2147/vhrm.s271411","title":"Direct Oral Anticoagulants for the Prevention and Acute Treatment of Cancer-Associated Thrombosis","year":2022,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Wilfrid Laurier University; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Edoxaban; Rivaroxaban; Apixaban; Cancer; Internal medicine; Low molecular weight heparin; Intensive care medicine; Population; Thrombosis; Warfarin; Atrial fibrillation","score_opus":0.07451950353282594,"score_gpt":0.4001270008317832,"score_spread":0.32560749729895727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304807925","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003475137,0.9907261,0.000057101453,0.00011390135,0.00027041414,0.008085779,0.00023940369,0.000034593657,0.0001251781],"genre_scores_gemma":[0.000028864997,0.99606574,0.00024208699,0.00010547465,0.00005480981,0.0027341156,0.00035491498,0.00005261035,0.0003613636],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978122,0.00027830797,0.00062783004,0.0005398818,0.0003330658,0.00040872747],"domain_scores_gemma":[0.9985186,0.00015423853,0.0006603167,0.00046684238,0.00002431165,0.00017572967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007636319,0.00038452202,0.002705562,0.0001984696,0.00049830385,0.000028127199,0.00010593193,0.00008484805,0.000054342923],"category_scores_gemma":[0.000014764972,0.00023041348,0.00061922683,0.0002606263,0.000055722216,0.000025019832,0.00014422969,0.00010452517,0.0000011518636],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001507861,0.00077923865,0.00028477178,0.019537585,0.015686205,0.00000390588,0.00018652264,0.0000021911414,5.975064e-9,0.00014136394,0.0015815386,0.9617816],"study_design_scores_gemma":[0.0015388442,0.0013965738,0.0016968984,0.0028467323,0.034401663,0.0000015894475,0.0001598233,0.000042418444,1.9664846e-7,0.000023093166,0.9577086,0.00018355841],"about_ca_topic_score_codex":0.0024935172,"about_ca_topic_score_gemma":0.00033977468,"teacher_disagreement_score":0.96159804,"about_ca_system_score_codex":0.00035217757,"about_ca_system_score_gemma":0.00016648628,"threshold_uncertainty_score":0.9395989},"labels":[],"label_agreement":null},{"id":"W4318263103","doi":"10.2147/vhrm.s394134","title":"Elevated Lp(a) Levels Correlate with Severe and Multiple Coronary Artery Stenotic Lesions","year":2023,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre","funders":"","keywords":"Medicine; Cardiology; Internal medicine; Coronary artery disease; Lipoprotein(a); Stenosis; Risk factor; Coronary arteries; Artery; Logistic regression; Cholesterol; Lipoprotein","score_opus":0.018674864920282724,"score_gpt":0.24680573218995366,"score_spread":0.22813086726967094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318263103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766841,0.01672701,0.0020423196,0.00079441024,0.0001570837,0.0029010614,0.000040769595,0.0002976798,0.0003556],"genre_scores_gemma":[0.8631118,0.13217545,0.002047512,0.0014336854,0.00010257028,0.000091733855,0.00015669472,0.00006695093,0.00081363093],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99780196,0.00018353315,0.000334557,0.00054331735,0.000535496,0.0006011515],"domain_scores_gemma":[0.9985464,0.00004379694,0.000105246654,0.00060266105,0.000050531387,0.0006513657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010390104,0.00024521127,0.0005205417,0.00023335588,0.00050481403,0.000030156389,0.00005648169,0.00008485098,0.000016970396],"category_scores_gemma":[0.000023989012,0.00017757759,0.00012545488,0.00046443928,0.000072679555,0.00006896866,0.00012147872,0.0002879544,0.000046800924],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045681422,0.00022210165,0.12861879,0.0041081216,0.0030654646,0.0011413086,0.0010884799,0.0004513334,0.000004036382,0.00053813134,0.0022651937,0.8580402],"study_design_scores_gemma":[0.008411835,0.0010575056,0.92319405,0.00063349534,0.0006209556,0.00046512362,0.001940645,0.00397848,0.0000031132067,0.00014748669,0.05920016,0.00034712846],"about_ca_topic_score_codex":0.0005586329,"about_ca_topic_score_gemma":0.00009412185,"teacher_disagreement_score":0.8576931,"about_ca_system_score_codex":0.000075514195,"about_ca_system_score_gemma":0.00013953407,"threshold_uncertainty_score":0.7241404},"labels":[],"label_agreement":null},{"id":"W4320912911","doi":"10.2147/vhrm.s394695","title":"Genetic Variants in PHACTR1 & LPL Mediate Restenosis Risk in Coronary Artery Patients","year":2023,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Coronary Interventions and Diagnostics","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre","funders":"","keywords":"Medicine; Internal medicine; Cardiology; Restenosis; Genetics; Biology","score_opus":0.017022531129938324,"score_gpt":0.27955084929346075,"score_spread":0.2625283181635224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320912911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99129796,0.006585567,0.0001616803,0.00022239887,0.0003164823,0.0011381943,0.000034394972,0.000050419847,0.00019291913],"genre_scores_gemma":[0.7179059,0.27995992,0.0010016436,0.00045350875,0.000045693258,0.00013626856,0.00019573436,0.0000261305,0.000275228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981094,0.0002180136,0.0005341876,0.0003867561,0.0002981423,0.0004535207],"domain_scores_gemma":[0.9991212,0.000088296496,0.00012583431,0.00038353435,0.000025705855,0.0002554375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006511909,0.00016109787,0.00031643827,0.0005412148,0.000107174186,0.000015207389,0.000073250245,0.0000494983,0.00003989935],"category_scores_gemma":[0.000105965715,0.00014550542,0.00009788204,0.000532404,0.00002775675,0.000039348684,0.00012974943,0.00021841543,0.00012822136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075813376,0.00046029192,0.7807465,0.00036400682,0.00009491309,0.00018920332,0.00035163044,0.00011229151,7.854405e-8,0.000019060204,0.0013496305,0.21623655],"study_design_scores_gemma":[0.0044739163,0.0003493335,0.9740769,0.00038538472,0.000102128826,0.0000041029966,0.00027630333,0.001091038,1.2029469e-7,0.00029920004,0.018816546,0.00012497806],"about_ca_topic_score_codex":0.0013644372,"about_ca_topic_score_gemma":0.0023352834,"teacher_disagreement_score":0.27339205,"about_ca_system_score_codex":0.00012148145,"about_ca_system_score_gemma":0.000045735622,"threshold_uncertainty_score":0.59335387},"labels":[],"label_agreement":null},{"id":"W4367060120","doi":"10.2147/vhrm.s405357","title":"Prevalence and Associated Factors of Cognitive Impairment Among Stroke Survivors at Comprehensive Specialized Hospitals in Northwest Ethiopia: Multi-Centered Cross-Sectional Study","year":2023,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"College of Medicine and Health Sciences, University of Gondar; University of Gondar","keywords":"Medicine; Stroke (engine); Cross-sectional study; Logistic regression; Cognition; Descriptive statistics; Montreal Cognitive Assessment; Multivariate analysis; Activities of daily living; Cognitive impairment; Physical therapy; Gerontology; Psychiatry; Internal medicine","score_opus":0.026091361156293576,"score_gpt":0.31299699619715327,"score_spread":0.2869056350408597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367060120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932014,0.0012796862,0.000031862433,0.00002527889,0.00021684951,0.0048461254,0.00023380147,0.000080922524,0.00008408571],"genre_scores_gemma":[0.97677267,0.021898607,0.000083978135,0.00007455225,0.000023383973,0.00013744913,0.00027841143,0.000029650259,0.00070129236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969379,0.0003194387,0.0007875556,0.0006951003,0.0007330492,0.00052701106],"domain_scores_gemma":[0.9986734,0.00018326126,0.00043038663,0.00028153323,0.00013183411,0.00029963147],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010124535,0.0003098254,0.000658661,0.00043681567,0.00022960268,0.000029977455,0.00009680112,0.00009658852,0.00002351504],"category_scores_gemma":[0.00011969382,0.0002737229,0.00014062514,0.00042437267,0.0001814278,0.00007589106,0.0004986755,0.0002662887,0.000005608836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023955344,0.0008668984,0.99280506,0.0010349398,0.0013088811,0.000064073574,0.0028794438,0.000023830973,0.0000011613283,0.0000029901123,0.000104047176,0.000669108],"study_design_scores_gemma":[0.012328978,0.0009402945,0.9791991,0.00033465665,0.00025800653,9.156956e-7,0.006216274,0.0003403016,0.0000075352987,0.0000015737559,0.00018229692,0.00019005158],"about_ca_topic_score_codex":0.004552058,"about_ca_topic_score_gemma":0.0025635061,"teacher_disagreement_score":0.020618921,"about_ca_system_score_codex":0.00033471227,"about_ca_system_score_gemma":0.000038271522,"threshold_uncertainty_score":0.9999715},"labels":[],"label_agreement":null},{"id":"W4390277074","doi":"10.2147/vhrm.s442108","title":"Prevalence and Factors Associated with Hypertension Among HIV Positive Patients on Antiretroviral Therapy: A Hospital-Based Cross-Sectional Study in Rwanda","year":2023,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre for Interdisciplinary Research in Rehabilitation","funders":"","keywords":"Medicine; Cross-sectional study; Odds ratio; Logistic regression; Confidence interval; Population; Antiretroviral therapy; Statistical significance; Odds; Public health; Human immunodeficiency virus (HIV); Internal medicine; Demography; Pediatrics; Viral load; Environmental health; Immunology","score_opus":0.017157254318637547,"score_gpt":0.2822261728771368,"score_spread":0.26506891855849923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390277074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964698,0.00048571307,0.0000098242235,0.000073020514,0.00004449807,0.0027600718,0.00004365775,0.00006486589,0.00004853019],"genre_scores_gemma":[0.9953259,0.00402305,0.000021198503,0.00015996533,0.000006361625,0.000107964566,0.00024468516,0.00001865587,0.00009219807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984731,0.00014861175,0.0002713001,0.00043800747,0.00036802125,0.0003009646],"domain_scores_gemma":[0.9993165,0.00006436487,0.00013445782,0.00020297548,0.000073273026,0.0002084161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034154652,0.00016794432,0.00024568063,0.0002764552,0.00039995724,0.000027190945,0.00003360915,0.00005463652,0.000002951414],"category_scores_gemma":[0.00002659764,0.000115478535,0.00003691273,0.00040018716,0.00005407344,0.00005058784,0.000026965343,0.00017994632,0.0000057241045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016575446,0.0014594506,0.99388945,0.00011048651,0.00020961116,0.00002137913,0.00048719282,0.000053690666,2.4524292e-8,0.0000059605673,0.00003528539,0.003561695],"study_design_scores_gemma":[0.008995422,0.0053680893,0.9838292,0.00030359457,0.00005518988,1.562584e-7,0.00017597422,0.0011250371,4.2427965e-7,0.0000067716746,0.000042153846,0.000097986696],"about_ca_topic_score_codex":0.0006690346,"about_ca_topic_score_gemma":0.000040204763,"teacher_disagreement_score":0.010060268,"about_ca_system_score_codex":0.00016661288,"about_ca_system_score_gemma":0.000060381986,"threshold_uncertainty_score":0.4709078},"labels":[],"label_agreement":null},{"id":"W4399897968","doi":"10.2147/vhrm.s391808","title":"Repurposing Metformin for the Treatment of Atrial Fibrillation: Current Insights","year":2024,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"Weill Cornell Medicine - Qatar; Weill Cornell Medical College","keywords":"Medicine; Atrial fibrillation; Metformin; Internal medicine; Repurposing; Diabetes mellitus; Cardiology; Current (fluid); Intensive care medicine; Insulin; Endocrinology","score_opus":0.01638758597438475,"score_gpt":0.29983318237722734,"score_spread":0.2834455964028426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399897968","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037550468,0.9561783,0.0045692907,0.000008638708,0.00075334875,0.00087137177,0.000019820342,0.000008718769,0.000040031948],"genre_scores_gemma":[0.0017320168,0.99655676,0.0005804608,0.000035373978,0.0009020528,0.000050023948,0.00005858848,0.000011763251,0.00007293124],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992097,0.000049843147,0.00021453154,0.00025571397,0.00010585958,0.00016433299],"domain_scores_gemma":[0.9995681,0.000022154969,0.00006715338,0.0002493319,0.000022445798,0.000070787515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023713989,0.00010817956,0.00015437373,0.000043018437,0.00015132577,0.000026933469,0.000049546627,0.000032019976,0.0000031140441],"category_scores_gemma":[0.000006755068,0.00006526427,0.00022706739,0.00007398747,0.000028155584,0.0000032180708,0.00002345441,0.000022726905,9.4715284e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039721082,0.000011999384,0.00007139062,0.000330693,0.00041712794,2.2444497e-7,0.00022870727,0.00016993692,0.0000019949994,0.0010116999,0.00066873844,0.9970478],"study_design_scores_gemma":[0.00064922875,0.00037950237,0.000023308066,0.000038353668,0.00022742966,4.7392808e-7,0.00009037844,0.00095855846,0.00040518038,0.00026767945,0.9968862,0.000073742296],"about_ca_topic_score_codex":0.000044592925,"about_ca_topic_score_gemma":0.000021768352,"teacher_disagreement_score":0.99697405,"about_ca_system_score_codex":0.000022789269,"about_ca_system_score_gemma":0.00006094142,"threshold_uncertainty_score":0.26613998},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W4401554217","doi":"10.2147/vhrm.s431612","title":"Interobserver Variability of Coronary Stenosis Characterized by Coronary Angiography: A Single-Center (Toronto General Hospital) Retrospective Chart Review by Staff Cardiologists","year":2024,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Cardiac Imaging and Diagnostics","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Coronary angiography; Retrospective cohort study; Stenosis; Single Center; Chart; General hospital; Cardiology; Radiology; Internal medicine; Emergency medicine; Myocardial infarction","score_opus":0.008375683840370924,"score_gpt":0.2534694073255018,"score_spread":0.2450937234851309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401554217","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2010283,0.7908075,0.001487586,0.0008240177,0.0007567002,0.0033834272,0.00092765666,0.00016668224,0.00061814726],"genre_scores_gemma":[0.2494324,0.7466139,0.00076180283,0.0015468928,0.0001269251,0.00027043858,0.001014528,0.00004619922,0.0001868735],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976451,0.00033784952,0.0005479995,0.00067774905,0.00037608377,0.00041521987],"domain_scores_gemma":[0.9988069,0.00005922786,0.00015429252,0.0005536432,0.000094605064,0.00033131425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010375159,0.00029348367,0.0009057964,0.00006823056,0.00008877019,0.000028630282,0.00008883983,0.000073980584,0.000043685603],"category_scores_gemma":[0.00004645817,0.00024036798,0.0006894021,0.00019231685,0.00012557741,0.000112824455,0.00014699865,0.00020061899,0.0000051882303],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016800466,0.0011688167,0.74660397,0.015388682,0.0037989933,0.000084238476,0.00032259407,4.1148655e-7,0.000018867477,0.000081475824,0.1461655,0.08619845],"study_design_scores_gemma":[0.0029181254,0.0025132524,0.48057872,0.005053021,0.0020808282,0.00003070982,0.0002759706,0.000043822183,0.000008461859,0.00005303501,0.50599355,0.0004504902],"about_ca_topic_score_codex":0.0008002204,"about_ca_topic_score_gemma":0.0000062796835,"teacher_disagreement_score":0.35982805,"about_ca_system_score_codex":0.00040615656,"about_ca_system_score_gemma":0.000050292347,"threshold_uncertainty_score":0.9801922},"labels":[],"label_agreement":null},{"id":"W4415916735","doi":"10.2147/vhrm.s559424","title":"The Effectiveness and Safety of Cardiac Shock Wave Therapy in the Treatment of Ischemic Heart Disease with Refractory Angina Pectoris","year":2025,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Pain Management and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Refractory (planetary science); Angina; Disease; Shock (circulatory); Heart failure; Ischemia; Cardiac function curve","score_opus":0.007254642037654335,"score_gpt":0.25988910567737605,"score_spread":0.2526344636397217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415916735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8404171,0.15468046,0.000086756314,0.00076242536,0.00004814254,0.0031421946,0.000008443849,0.000010718039,0.0008437478],"genre_scores_gemma":[0.62822,0.37126857,0.00009108724,0.00011596042,0.0000125776005,0.00017894717,0.000011411983,0.0000066810435,0.000094739655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870497,0.00043346966,0.00020947942,0.0002357062,0.00021381077,0.0002025551],"domain_scores_gemma":[0.9991333,0.00024561145,0.00007891091,0.00043764585,0.000023073151,0.0000814618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092247425,0.00015614888,0.00035506522,0.000106338666,0.00016514452,0.000009498656,0.000043017,0.000020371275,8.825812e-7],"category_scores_gemma":[0.000008373954,0.00007232623,0.000099423116,0.00022832208,0.00009300034,0.000020596442,0.000022264981,0.000057746503,2.2597486e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003946137,0.001236284,0.6057634,0.0015504193,0.0021272874,0.000018729948,0.0010690722,0.000012389561,0.0000037413515,0.0015185759,0.00044708294,0.3823069],"study_design_scores_gemma":[0.0038342963,0.0013076673,0.79302794,0.00023357673,0.00036982822,3.0348303e-7,0.00082329434,0.00003069412,0.000023117538,0.00009184949,0.20020111,0.000056328496],"about_ca_topic_score_codex":0.00043948332,"about_ca_topic_score_gemma":0.000024174808,"teacher_disagreement_score":0.38225058,"about_ca_system_score_codex":0.00011304956,"about_ca_system_score_gemma":0.00005758635,"threshold_uncertainty_score":0.2949378},"labels":[],"label_agreement":null}]}